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Abstract 
The thymus constitutes the primary lymphoid organ responsible for the generation of naïve T cells. 
Its stromal compartment is composed of a scaffold of different subsets of epithelial cells that provide 
soluble and membrane-bound molecules essential for thymocyte maturation and selection. With 
senescence, a steady decline in the thymic output of T cells has been observed. Numeric and 
qualitative changes in the stromal compartment of the thymus resulting in reduced thymopoietic 
capacity have been suggested to account for this physiological process. The precise cellular and 
molecular mechanisms underlying thymic senescence are, however, only incompletely understood. 
Here, we demonstrate that TGFβ signaling in thymic epithelial cells exerts a direct influence on the 
cell’s capacity to support thymopoiesis in the aged mouse as the physiological process of thymic 
senescence is mitigated in mice deficient for the expression of TGFβ receptor type II on thymic 
epithelial cells. Moreover, TGFβ signaling in these stromal cells transiently hinders the early phase 
of thymic reconstitution following myeloablative conditioning and hematopoietic stem cell 
transplantation. Hence, inhibition of TGFβ signaling decelerates the process of age-related thymic 
involution and may hasten the reconstitution of regular thymopoiesis following hematopoietic stem 
cell transplantation. 
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1. Introduction 
 
1.1  A general introduction to the thymus  
 
The thymus is the primary organ of T-lymphopoiesis. As a mere “transit” organ – allowing 
differentiation of pro-thymocytes  to naïve T cells –  the thymus does not house stem cells with self-
renewing potential1, and thus requires continuous ‘feeding by seeding’ of blood-bourne precursor cells 
from the bone marrow. The reason for the inability of the thymus to accommodate and keep stem cells 
in an undifferentiated state remains unknown. However, the issue of out-sourcing T cell development 
to a specialized tissue (i.e. thymus) is remarkably conserved during evolution, with cartilaginous fish 
being the most ancient representatives showing spatially clearly definable T cell development 2.  
 
1.1.1 Organogenesis of the thymus 
 
The microenvironment supporting T cell development consists of epithelial cells, fibroblasts and HSC-
derived dendritic cells. Thymic epithelium is a derivative from the 3rd pouch endoderm 3, which buds 
out into the surrounding mesenchyme. Interaction with mesenchymal cells – partly of neural crest 
origin – and HSC-derived cells, but also cell-autonomous processes are required for the development 
and maturation of the epithelial compartment. The latter include the expression of genes encoding 
transcription factors, such as homeotic genes. 
 
1.1.2 Cell-autonomous processes in TEC development 
 
Expression of the transcription factor Foxn1 (forkhead box n1, previously called winged helix nude 
(whn) or hepatocyte nuclear factor 3/forkhead homolog11 hfh11; gene localized on chromosome 11) 
identifies cells with a thymic fate. Yet, commitment of the endodermal lining to thymic epithelial cell 
lineage is likely to occur before Foxn1 expression can be traced at E11.25 in the ventral aspect of the 
3rd pouch. However, earlier markers distinguishing committed thymic epithelial precursors are not yet 
available.  
The requirement of Foxn1 expression does not apply to the formation of the primordium 4 but is 
important for the differentiation and function of thymic epithelium 5. Foxn1 deficiency leads to an 
arrest in thymic epithelial cell (TEC) differentiation at an early stage, which precludes immigration of 
thymocyte precursors into the rudiment and ultimately results in severe T cell immunodeficiency (6), as 
demonstrated by the naturally occurring nude (nu/nu) mutant, as a result of defective Foxn1 expression. 
On the other hand, expression of Foxn1 in epithelial cells within the thymic rudiment of nude mice 
results in the development of thymic lobuli containing specialized compartments, to which T cell 
progenitors are attracted and T cell development is efficiently supported 7. The fact that only a 
relatively small fraction of TEC in the adult mouse expresses Foxn1 is in line with the notion that 
Foxn1 expression is not continuously required but is essential for TEC differentiation 8. Thymic 
epithelium devoid of Foxn1 expression – as seen in nu/nu mice – fails to acquire markers of committed 
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TE, and is incompetent to attract lymphoid precursors, potentially due to dysregulated chemokine 
production9.  
Foxn1 is expressed not only in developing TECs 6, 5 but also in keratinocytes and precursor cells of the 
hair bulge 10 . In mice, its expression marks the first step of terminal differentiation of the dermal 
epithelium and thus is found in the first suprabasal layer of the epidermis and in the supramatrical 
region of the hair bulb 11.  Mutations leading to inactivation of Foxn1 affects keratinization of 
epidermis and hair shaft 12, 13, 10,  thus impairing coat and stratum corneum formation. The informations 
about Foxn1-regulated molecules are scarce but include PKC in keratinocytes and acidic hair keratin 3 
in the hair follicle 13, 10.  
Hoxa3 is a member of the transcriptional regulator – Hox – gene family, containing a homeobox 
sequence. Expression of Hoxa3 in the pharyngeal endoderm and neural crest can be detected as early as 
E8.5 14. Inactivation of the gene results in complete athymia, due to a failure of the 3rd pouch endoderm 
to detach from the foregut and form a thymic primordium. In addition, apoptosis in the 3rd pouch 
endoderm was increased in Hoxa3-/- embryos 15. Yet number and migration of neural crest-derived cells 
was not affected in these mutants 15,16. Hoxa3 is required for the sustained expression of Pax-1 and 
Pax-9, which are expressed in 3rd pouch endoderm from E9.5 onwards. These two members of the Pax 
family of transcription factors are involved in the proper formation of the thymus. Interestingly, the 
fine-tuned expression of Hoxa3 in the 3rd pouch region is crucial for the development of 3rd pouch 
derivatives. Increased Hoxa3 expression due to retinoic acid-exposure increases Pax1 expression17,18. 
This correlates with severe thymic hypoplasia as well as ectopia and as a consequence thymocyte 
development is severely perturbed.  
Pax-1 is detected in the 3rd pouch endoderm as early as E10, remains expressed in the developing 
thymus and postnatally in a subpopulation of cortical stromal cells. Pax1-deficient embryos show a 
normal thymic development and migration until E13.5.  Thereafter, the thymus fails to grow in size and 
is unable to support regular thymocyte development 19-21. However, Foxn1-expression is unaffected by 
the absence of Pax-1.  
The expression of Pax-9, a paralog of Pax-1 is detected around E9 – i.e. prior to Pax-1 expression – in 
the pharyngeal endoderm and in neural crest-derived cells. Pax-1 and -9 are the only Pax family 
members, which are not expressed in the central nervous system but – with the exception of the thymus 
anlage and the facial skeleton – are detected in structures undergoing chondrogenesis (reviewed in 22). 
Pax-9 is not required for the formation of the thymic anlage, but in its absence the 3rd pouch endoderm 
fails to detach from the foregut. The result is a bilateral polyp-like structure in the larynx region, which 
expresses Foxn1, IL-7 and SCF and is able to attract thymocyte precursors. Yet, thymocyte 
development is severely perturbed due in part to increased thymocyte apoptosis 23-25. The specific roles 
for these two Pax family members in thymic development remain to be addressed but probably include 
the regulation of genes involved in cell differentiation and apoptosis 26.  
Besides these cell-autonomous regulators of TEC differentiation and migration, interactions known as 
cross-talk with other cells in situ, including thymocytes and mesenchymal cells,  play a crucial role in 
the differentiation of TEC precursors into terminally differentiated cortical and medullary epithelial 
cells with distinct phenotypic and functional characteristics.  
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1.1.3 Surface molecules expressed by TEC 
 
The identification of thymic epithelial subpopulations was addressed using morphological and 
ultrastructural characteristics as well as antigenic determinants applying a panel of antibodies 27-29. 
Antibody-mediated staining of cytokeratins has proven particularly useful and has – in conjunction 
with other markers, such as UEA-1 and MTS-10 – led to the classification of distinct thymic epithelial 
subsets 30.  
The major keratins expressed in the thymus include the type II keratins K5 and K8. They assemble 
with the type I keratins K14 (for K5) and K18 (for K8). The major cortical TEC subset expresses both 
K8 and K18, whereas the major medullary subset of thymic epithelia co-expresses K5 and K14, and in 
addition stains for MTS10. Minor subsets include cortical K8+K18+K5+ expressing cells and medullary 
K5-K14-K8+K18+UEA1+ cells. Although a differential expression of cytokeratins in different TEC 
subsets may imply a direct or indirect role in their specialized function, this remains to be addressed.  
It is easily perceived that for the multitude of tasks performed by stromal cells tight intercellular 
interactions between TEC themselves or between TEC and thymocytes are required. A number of 
adhesion molecules facilitate these encounters.  
 
Cadherin family members play a crucial role in the formation of adherens junctions in keratinocytes 31. 
The majority of cadherins solely mediate Ca2+-dependent homophilic adhesive interactions. Yet, E-
Cadherin forms also a heterophilic interface with the integrin αE (CD103) β7 heterodimer, which is 
expressed by several thymocyte subpopulations 32,33. In the adult thymus E-Cadherin expression is 
largely confined to the epithelium, however, fetal thymocytes – in particular CD4-CD8-CD25+ 
precursor stages also show a strong surface staining for this molecule 33. Different studies demonstrated 
the essential contributions of these homo- and heterophilic interactions for the in vitro development of 
a functional thymic organoid 32-34. The regulation of E-Cadherin expression in TEC is to date unknown. 
Cell-cell interaction is however not only required for the structural integrity of the stroma as it was 
shown that B7 and ICAM-1 (expressed on cortical and medullary TEC) as well as VCAM-1 (expressed 
on HSC-derived APC) are important for thymocyte selection processes35,36. The expression of MHC 
class II molecules on the surface of thymic epithelium is required for their essential role in T cell 
development 37.  
 
1.1.4 Cell-cell interactions in TEC development 
 
The influence of maturing thymocytes on the developing epithelium during embryogenesis has long 
been appreciated 30,38-41. Mice with a block in thymocyte development at different stages have proven 
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helpful for the study of this interaction. The hCD3ε26 transgenic mouse line shows a developmental 
arrest of thymocytes at the DN1 stage. TEC differentiation in these mice is restricted to an immature 
K5+K8+ phenotype. The TEC display a disorganized cortical architecture while a separate medullary 
region is completely lacking. Whereas Rag1-/- mice with their developmental arrest at the DN3 stage of 
thymopoiesis also lack a medulla, their cortical epithelial compartment shows proper maturation with a 
large population of mature K8+K5- TEC. Maturation of TEC in these mice can be achieved by 
transferring wildtype hematopoietic stem cells with a normal thymocyte development.  
Interestingly, the plasticity of the epithelial compartment is retained only during a relatively short 
period of time, as hCD3ε26 transgenic mice develop a normally sized and functional thymus only if 
normal prothymocytes reach the thymus during embryonic development. A recent paper however 
questions the requirement of lymphocyte precursors for the differentiation of TEC 42. Using hCD3ε26 
transgenic mice, Jenkinson et al. demonstrate, that the presence of normal T cell development during 
embryogenesis is not required for the initial steps of TEC differentiation (measured by cytokeratin 
stainings and Aire and Plunc expression). However, this study does not provide an explanation for the 
phenotypically immature stages of thymic epithelium in the adult hCD3ε26 mouse.  
 
During embryogenesis, neural crest-derived mesenchymal cells surround and later invade the epithelial 
rudiment, forming a network, interacting with epithelial and lymphoid cells. A study, using a neural 
crest-specific marker has demonstrated the intimate relation between these cells and the endoderm-
derived thymic primordium43. However, at later time points, i.e. in the newborn mouse, NCC-
derivatives are restricted to a small portion in the posterior thymic capsule. Whereas the patterning of 
pharyngeal arches occurs independently of neural crest cells in the chick embryo44, the importance of 
neural crest-derived cells not only for epithelial differentiation but also for thymocyte development is 
demonstrated by experiments involving neural crest ablation or depletion of surrounding mesenchyme 
in culture systems 45,46. Potential mechanisms include the secretion and membrane-bound presentation 
of growth and differentiation factors. These molecules may act either directly or be deposited in the 
extracellular matrix, which is itself produced by stromal cells45,47,48. Likely candidates for such growth 
and differentiation factors are fibroblast growth factors (FGF) and TGFβ family members. Indeed, TEC 
deficient in the expression of FGFR2IIIb – the receptor for FGF7 and FGF10, which are typically 
detected in the mesenchyme surrounding the thymic primordium – fail to proliferate and demonstrate a 
partial block in differentiation. Despite these alterations, normal thymocyte development is not 
affected. Ablation of FGF10 – a ligand for FGFR2-IIIb –results in a similar though somewhat 
mitigated phenotype49. Pax-1 and Pax-9 expression is not disturbed by the absence of FGFR2-IIIb 
expression. PDGFRa+ mesenchymal cells are transiently important for the expansion of epithelial cells 
and, as a consequence, for the quantity of intrathymic niches available for thymocyte precursors 50. In 
addition to their role in TEC expansion, mesenchymal cells and extracellular matrix molecules 
provided by them, are required for the differentiation of prothymocytes (in particular at the DN2 stage) 
but not of DP thymocytes 45,47.  
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Neural-crest cells – a vertebrate ‘invention’ – develop at the border between the neural plate and the 
epidermis, delaminate from the dorsal part of the neural tube after its closure and acquire a high grade 
of mobility. They differentiate into a multitude of specialized cells such as neurons, glial cells, pigment 
cells as well as craniofacial cartilage and bone. The induction of the neural crest is tightly regulated by 
BMP and Wnt signaling in an antagonistic fashion 51,52.  
The induction, differentiation, proliferation, maintenance and migration of NCC rely on timed Hoxa3 
expression, as its absence results in delayed differentiation and malformation of the third arch53. The 
expression of Hoxa3 therefore influences TEC development both in a cell-autonomous direct fashion 
via TEC as well as in an indirect way via expression in NCC.  
TGFβ-family members instructively influence differential specifications of NC stem cells in vitro 54-56, 
whereby the concentration and combination of signals provided by these molecules determine the fate 
of NCC57. Recent reports highlight the involvement of several TGFβ-signaling components in late 
specification and survival of NCC 58-64. The importance of TGFβRII-mediated TGFβ signaling in 
neural crest-derived cells was demonstrated65, since the absence of functional TGFβRII in NCC led to 
the loss of region-specific differentiation (but did not affect cell migration). As a consequence features 
typically seen in DiGeorge syndrome such as thymic and parathyroid hypoplasia develop in these mice. 
Furthermore, a recent study has demonstrated the involvement of the common mediator of TGF/BMP-
signalling mediator Smad4 in the maintenance of NCCs. A potential role for TGFβ during thymic 
development might therefore lay in the instruction of NCCs to acquire their requested region-specific 
phenotype. However, both the nature of the cell types providing this cytokine and the identity of 
additional signals other than TGFβ remain to be investigated.  
 
1.1.5 Thymocyte development 
 
A continuous supply of T cell precursors is crucial for thymopoiesis, as the thymus lacks hematopoietic 
stem cells and supposedly also the niches needed for their survival. Substantial effort has gone into the 
identification of the phenotype of precursors with intrinsic T-lineage potential. This has led to the 
characterization of separate precursor populations that have individual lineage potentials. The 
subsequent development of these precursors into mature T cells requires their dramatic expansion. 
Indeed, each single precursor will give rise in two separate ways to roughly 106 descendants. This 
expansion is effected by a 4000-fold expansion at the DN and by a 250-fold expansion of the early DP 
stages.  
Homing of blood-bourne precursors to the intrathymic microenvironment is considered a rare event 
with only an estimated 200 cells entering on a single day66. Progenitor cells enter the thymus through 
transmigration of postcapillary venules in the region of the corticomedullary junction 67. A recent 
report has shown that PSGL-1 expression on homing cells greatly facilitates this process as it allows 
the binding of P-selectin, that is typically expressed on thymic endothelial cells. Availability of empty 
progenitor cell niches by a yet unknown mechanism leads to up-regulation of P-selectin on the 
endothelium 68. Several chemokines have been implicated in the attraction of prothymocytes. Whereas 
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thymic vasculature is involved in the attraction of prothymocytes in the adult, gathering of thymocyte 
precursors in the fetus occurs prior to vasculatisation of the thymus.  
Bleul and Boehm9 demonstrate the constitutive expression of CCL21, CCL25 and CXCL12 in the 
alymphoid thymic anlage and show that CCL25 and CXCL12 act as strong chemoattractants to fetal 
thymocyte precursors whereas CCL19 was much less potent. Mice deficient for the functional 
transcription factor Foxn1, show a normal thymic anlage by E12.5 however lack the immigration of 
thymocyte precursors. Detailed analysis showed that the presumptive thymus is devoid of CCL25 and 
CXCL12 message. Surrounding tissue on the other hand expressed normal CXCL12 levels. 
Interestingly, the adjacent parathyroid in wildtype as well as in nude mice shows high expression of 
CCL21. Mice deficient for the CCL25 receptor CCR9 do not show a defect in thymocyte development 
under steady-state conditions. However, they reveal a disadvantage in repopulating the thymus under 
competitive conditions69, despite the absence of the receptor on wildtype DN cells. Liu et al. extend 
these findings, analyzing embryos lacking the expression of CCR7 and CCR9, the receptors for 
CCL19/CCL21 and CCL25 respectively, and find a synergistic effect of signaling via the two receptors 
in attracting precursors to the thymic anlage. Expression of CCR7, the receptor for CCL19 and CCL21, 
is restricted to immature CD25int CD44+ thymocytes (i.e. cells at the DN1→DN2 transition), and its 
lack prevents the migration of DN2 to the outer cortex, which results in the disturbance of early T cell 
development (e.g. the accumulation of DN1) and a reduced number of thymocytes70. Chemokines are 
mainly produced by thymic epithelia in the different anatomical compartments, though other stromal 
cells also contribute to their production 71, 9, 72. The consecutive steps during thymopoiesis, i.e. 
proliferation and further maturation are regulated by additional members of the chemokine family. 
CXCL12 (a.k.a. stroma-derived factor-1 (SDF-1), pre-B cell growth stimulating facor (PBSF)), 
originally isolated from bone marrow stromal cell73, and its corresponding receptor CXCR4 are 
involved in the development and function of multiple organ systems73-76. CXCL12 is ubiquitously 
expressed in the E14 thymus77. Attraction of prothymocytes is however not influenced by the absence 
of CXCR477, but a dramatic increase in the number of post-DN2 thymocytes ensues and is observed in 
thymi of CXCR4-/- mice at different embryonic stages. This is due to an expansion deficit at the DN3 
and DN4 stages, is noted as early as E13.5 and appears to be independent of the pro-survival factor bcl-
2. The same study demonstrates a synergistic effect of CXCL12 on SCF-mediated survival of DN2 
cells. Plotkin et al. demonstrate78 the expression of CXCR4 on all DN thymocytes and CXCL12 
expression on a subpopulation of cortical TEC in adult mice. Conditional inactivation of CXCR4 in 
DN leads to their retention at the corticomedullary junction and arrests their development at the DN1 
stage.  
The earliest intrathymic progenitors (DN1) will remain in a state of asymmetrical division in the zone 
of entry at the corticomedullary junction for an extended period of about 10 days79, 80. Here,  survival, 
proliferation and differentiation signals are provided by IL-7, whereas SCF enhances their proliferation 
and inhibits their differentiation. In addition, Flt3 affects in a largely positive manner their expansion81. 
The transition to DN2 is recognized by the up-regulation of CD25 and expression of RAG. Restriction 
to the T cell-lineage is mediated through Notch signaling at the DN3 stage, which is phenotypically 
characterized by the down-regulation of the CD44 expression, and genotypically by the V-DJ 
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rearrangement of the TCRβ locus. In-frame rearrangement of one TCRβ allele is a prerequisite for 
further survival and maturation to the DN4 (CD44- CD25-) stage. Here, cells express on their surface 
the pre-TCR, a yet immature form of the TCR, allowing them to receive survival signals, a process 
referred to as β-selection. DN4 cells then undergo further rounds of proliferation, start to recombine the 
TCRα locus and up-regulate the expression of CD4 and CD8, characteristics of the DP stage of 
thymopoiesis.  
During the development of DN1 thymocytes to DN4 cells Notch signaling plays a key role for 
specification and survival. Conditional inactivation of Notch1 in BM cells not only leads to a complete 
developmental block at the DN1 stage but also re-directs the intrathymic cells towards a B cell fate 
82,83. Notch-dependent signals are also implicated in the TCRβ gene rearrangement as well as in the 
elimination of thymocytes that did not receive a survival signal through the pre-TCR84,85. The 
contribution of Notch signaling to the decision regarding CD4 versus CD8 lineage commitment is still 
debated, yet survival of DP cells no longer depends on Notch signaling 85. 
CD4+CD8+ thymocytes mark the next key step in development. Their average live span is estimated to 
be 3-4 days. Interaction of TCRαβ expressed by DP and MHC molecules on radio-resistant stromal 
cells during this period determines the fate of DP.  Failure to successfully recognize MHC molecules 
commits the individual DP cell to down-regulate  anti-apoptotic molecules. The provision of pro-
survival signaling via RORγ and Wnt molecules allow limited survival of DP cells, wich further 
increases the chance of rearranging the TCRα locus to attain TCRαβ that can be positively selected. It 
is currently believed that low-abundance, low-affinity peptides presented by MHC molecules on 
cortical epithelium, but not on other types of epithelial cells89 promote positive selection 90. The erratic 
movement of pre-selection DP, termed ‘random walk migration`, is swiftly transformed into a rapid, 
directed movement towards the medulla upon positive selection 93. 
Negative selection of the generated TCR repertoire assures non-self reactivity among mature T cells. 
Depending on the experimental model used, this process may occur at different stages of thymocyte 
development. This observation has been related to a differential localization of specific accessory cells 
(i.e. macrophages, dendritic cells, possibly B cells and fibroblasts), and expression levels of TCR. 
Intrathymic dendritic cells were shown in different experimental models to play a dominant role in 
tolerance-induction by negative selection91. 
Single-positive (i.e. CD4+CD8- or CD4-CD8+) thymocytes, that have successfully completed thymic 
selection reside in the medulla for a period of up to 14 days 94. Initially functionally incompetent 95 and 
susceptible to various apoptotic stimuli, single-positive (SP) T cells undergo a series of maturational 
steps prior to their release into the periphery as mature T cells 96, 97, 98, 39. Phenotypically the SP 
thymocytes in this phase display changes in the cell surface expression of markers including CD24 
(HSA), CD69, CD62L, 3G11 and 6C10 99. In addition, CD3 expression is upregulated 100.  
Despite the thymocytes long residence in the medulla corresponding to roughly half of their lifespan 86, 
cellular and molecular mechanisms responsible for the post-selection maturation of SP during their 
sejourn in the medulla are still largely undefined. Nonetheless this residence constitutes a crucial phase 
in thymocyte development. The functional immaturity assigned to post-selection DP is characterized 
by an increased susceptibility for corticosteroid exposure or TCR ligation by antibodies 101, 102, 103. In 
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addition, proliferation of Qa2negative (i.e. HSAhigh) SP cells in response TCR ligation is diminished in 
comparison to mature T cells 95.  
The process of negative selection is among the maturational events that occur at the SP stage. This 
event is dictated by the TCR specificity and the MHC expression in the thymic medulla104. Different 
experimental approaches (e.g. injection of anti-TCR mAb or superantigens in mice; stimulation of 
isolated thymocyte subpopulations in vitro with anti-TCR in the presence or absence of co-stimulation; 
etc) have been used in an attempt to study this important process that will eliminate potentially auto-
reactive thymocytes. A series of studies by Kishimoto et al.103,105,106 have demonstrated the differential 
receptiveness of SP subpopulations (in particular CD4+ SP) to TCR engagement, measured as a 
function of apoptosis and proliferation. Whereas DP thymocytes rapidly undergo apoptosis upon TCR 
stimulation in the presence of co-stimulation, HSAhigh SP are more resistant to such stimuli (despite 
their higher TCR expression levels when compared to DP). Moreover, the most mature SP (as 
identified by low HAS expression) respond to TCR stimulation with activation and proliferation. In 
parallel, the dependency on co-receptor mediated signaling increases from the DP cell stage 
(characterized by a lack of apoptosis, and the consequential up-regulation of CD69 and CD25) to the 
stage of immature and finally mature SP cells, the latter also encompassing cells in the periphery. 
Furthermore, a requirement for Fas-FasL signaling depends on the maturational stage at which it 
occurs during thymopoiesis, as apoptosis of DP and immature SP with low TCR expression is fully 
independent of Fas. However, Programmed cell death of immature SP with high levels of TCR 
expression is completely dependent on Fas-FasL interaction. Alterations in the receptiveness of 
thymocytes to TCR-associated signals occur with differentiation thus leading to different 
interpretations of the same signal 107. This plasticity prepares T cells for optimal effector functions once 
they exit to the periphery. TCR-MHC interaction during the transition through the medulla is 
instrumental in adjusting peripheral T cell reactivity to a higher antigen threshold 108.  
Few molecules have been identified as surrogate markers for TCR-MHC affinity. Ror Example, CD4 
expression increases proportionally to the strength of the contact between TCR and MHC molecule. In 
this context, CD5 is thought to be  a negative regulator of TCR signal transduction initially after 
positive selection109. However, CD5 is not required  for the ‘dampening’ effect of the medullary 
education phase 108.  
A significant proportion of mature TCRhigh SP thymocytes undergo some level of stroma-dependent, 
IL-7 driven proliferation immediately before egress into the periphery. This proliferation requires and 
correlates with a TCR-MHC interaction, but does not change the activation status of the cell (i.e. fails 
to up-regulate as a result neither CD44 nor CD69). This post-selection expansion is induced by thymic 
epithelium and potentially other stromal components 110-113.  
 
1.1.6 Thymocyte migration 
 
The ability to enter the thymus, to migrate within the different thymic compartments, and to exit at the 
appropriate location and developmental stage requires precise regulation. A key role in these processes 
is attributed to chemokines.  
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CCR9 – the receptor for CCL25 (TECK) – is highly expressed on DP thymocytes and down-regulated 
during maturation to SP cells. Following positive selection, DP thymocytes migrate towards the ligand 
in vitro 114. Nevertheless, the targeted deletion of CCR9 does not result in obvious alterations of 
thymocyte development. Yet, a thorough analysis of the localization of the thymocyte subpopulations, 
which might reveal alterations in aberrant compartimentalisation of DP, has not been published. In 
contrast, CCR7 is upregulated during the transition from DP to SP 116 and CCR7- or CCR7L-deficient 
SP thymocytes fail to migrate to the medulla and accumulate in the cortex115. The relevance of these 
findings is of particular importance, as negative selection of SP thymocytes to AIRE-dependent, 
‘promiscuously expressed’ antigens requires their presence in the medulla and the lack of migration 
leads to autoimmunity towards these antigens. Interestingly, phenotypic maturation and export are not 
impaired in the absence of CCR7-CCR7L interaction, indicating that for these processes the thymic 
medulla and its structures are dispensable.  
Following negative selection, mature SP thymocytes are reach systemic circulation via medullary 
blood vessels 117,118. It was appreciated more than 25 years ago, that egress of mature thymocytes is an 
active, G protein signaling-dependent process 119. However, several mechanisms are involved: 
Attraction by circulating factor(s), loss of responsiveness to thymic retention factors and repulsion by 
thymic mediators. To date, key players key players include the following ligand/receptor pairs: 
sphingosine-1-phosphate(S1P)/S1P, CXCL12 (SDF-1)/CXCR4, CCL19/CCR7, CCL25/CCR9 and 
CCL22/CCR4.  
Under steady-state conditions, S1P is constitutively detected at relatively high levels in the plasma. S1P 
receptor 1 (S1P1) is expressed by the most mature thymocytes 116, 115. Chemotaxis towards S1P is 
exclusively displayed by mature thymocytes and resting peripheral T cells 116. Inactivation of S1P1 in 
HSC blocks export of mature T cells and leads to their accumulation in the thymus.  CXCL12 (SDF-1) 
is highly expressed in thymic tissue, BM and peripheral lymphoid organs 120 and demonstrates a 
fugetactic effect on activated T cells at high concentration 121. Its sole ligand is CXCR4, and deletion of 
either component results in an almost identical phenotype with multiple developmental defects and 
increased fetal lethality 73,122. As these mice do not survive the perinatal period, the effect of the lack of 
either molecule on thymocyte emigration could not be studied in vivo 121, yet CXCL12-deficient mice 
show essentially normal T cell development. Human mature thymocytes and peripheral T cells 
demonstrate active movement away from the chemokine121, which hints towards a role for these partner 
molecules in thymocyte export. Fetal thymic organ cultures using thymi derived from CXCR4-
deficient or wildtype mice confirmed these finding as CXCR4-/- mature SP accumulated 
intrathymically 123. In addition, specific pharmacological inhibition of CXCR4 leads to the 
accumulation of intrathymic mature SP thymocytes. Another chemokine-receptor pairing implicated in 
thymocyte egress consists of CCL19 and CCR7. In vitro and in vivo assays demonstrate, that CCL19 
but not CCL21 (which also binds to CCR7) is a potent chemoattractant for mature SP in the neonatal 
condition 124. 
Potential retention factors, preventing untimely exit of not yet fully educated thymocytes, include 
CCL25/CCR9 and CCL22/CCR4. Accordingly, CCR9 is highly expressed on DP thymocytes, but 
down-regulated in SP thymocytes 125, 114. In addition, DP but not SP thymocytes are attracted by 
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CCL22 (MDC) 126. Through a yet unknown mechanism not attributable to increased negative selection, 
exogenous TCR engagement of mature SP thymocytes impedes their egress 127.  
Once mature thymocytes leave the confines of the thymus as so called recent thymic emigrants (RTE), 
they become relatively difficult to detect in the peripheral T cell pool due to their phenotypic 
resemblance to naïve T cells 132,133. RTEs are of particular significance to the organism, as they 
maintain the diversity of the peripheral T cell pool 134,135. A multitude of studies address the 
identification and quantification of RTE, in order to measure thymic export. The frequency of RTE in 
the periphery directly correlates with the amount of functional thymic tissue. In mice it rapidly 
increases after birth and gradually declines after a peak at 6 weeks of age 136, 137. The export rate is 
independent of the pool size of peripheral T cells, into which RTEs become rapidly integrated 136,138.  
Besides tight regulation of thymic export, immigration of mature peripheral T cells into the thymic 
confinements is largely impeded. Peripheral naïve T cells cannot be detected within the thymocyte 
pool, even after intravenous injection of vast numbers of naïve syngeneic T cells. These findings 
however do not apply to newborn mice 140 nor to aged mice 137, indicating leakiness of the blood-
thymus barrier in these circumstances.  In addition, activated T cells could easily be detected as early 
as 24 hrs post-injection 139.  
 
1.2 Thymic involution 
 
Thymic function is measured by its ability to provide the organism with newly generated, appropriately 
selected T cells, thus ensuring a sufficient number of peripheral T cells with a broad repertoire of T cell 
receptor specificities tolerant to self. Even though the thymus retains the ability to produce T cells even 
in aged individuals 141, this capacity declines with age-associated involution. Thymic involution shows 
a biphasic course with a rapid loss of thymic tissue during puberty followed by a slow but constant rate 
of involution (reviewed in 142, 143, 144). The decrease in thymic output does lead to a decreased 
number of peripheral T cell, as they regulate their number in response to homeostatic signals. This is 
reflected by the increase in memory T cells and decrease of naïve T cells in the blood of the elderly. 
However, this process slowly lessens the variability of the TCR repertoire and eventually leads to an 
accumulation of ‘senescent’ T cells with reduced capacity to appropriately respond to antigens and IL-
2 145, 146. A characteristic feature of age-associated changes in the peripheral T cell pool includes the 
decrease in the CD4/CD8 ratio from roughly 1.8 in young individuals to about 1.0 in older subjects. 
Furthermore, the higher rate of proliferation is associated with reduced telomere length and higher 
susceptibility to apoptotic stimuli. Several functional changes, such as the reduced expression of 
effector molecules and cytokines, have been observed in T cells from aged humans (reviewed in 147). 
These alterations put the ageing organism at a higher risk to succumb to infections that are normally 
controlled by the ‘young’ immune system and reduce the efficacy of vaccinations 148. An increase in 
tumor incidence was also partially attributed to the reduced immune function in the elderly.  
Changes in the lymphoid as well as in the stromal compartment of the thymus contribute to its 
involution, as outlined in the following chapters. 
 
 17   
1.2.1 Quantitative and qualitative changes in the T cell progenitor pool 
 
The potential of common lymphoid progenitors to commit towards the T cell lineage decreases with 
age. In mice, this decline depends on strain-specific genetic modifiers, which remain to be identified 
149. In addition, the potential of hematopoietic precursors to home to the thymus is diminished in old 
mice 150, demonstrated by comparative transfer of precursors derived from young and aged mice into 
non-irradiated hosts 151,152-154, 155. 
 
1.2.2 Trafficking 
 
The egress of lymphoid progenitors from BM underlies active regulation, although the exact 
mechanisms involved remain unknown. There is evidence that this export is synchronized to 
concomitant receptivity of the thymus 156, 157. A potential thymus-bone marrow feedback loop might be 
established through either soluble or cellular components (or a combination of the two). Candidates 
regulating prothymocyte mobilization include CD44, β2m, SDF, TECK, α4 integrins and NK T cells.  
 
1.2.3 Thymic receptivity 
 
In addition to pre-tymic alterations, intrathymic changes modify the occurrence and rate of thymic 
involution. Availability and appropriate signaling of empty niches for early thymocyte progenitors 
(ETP) within the thymus seems important and is closely linked to progenitor export from the bone 
marrow. Importation of ETP is facilitated by the expression of homing molecules on stromal and 
lymphoid cells. Expression of P-selectin on endothelium or of Flt3 Ligand on perivascular fibroblasts 
and expression of the corresponding ligands PSGL-168 or Flt3158 respectively on ETP enhances their 
homing. As the absolute number of niches for ETP directly correlates with the number of thymic 
stromal cells 152, a decrease in TEC numbers in the aged mouse consecutively results in decreased 
numbers of ETP. However, ETP derived from old mice also demonstrate a reduced proliferative 
potential as well as an increase in apoptosis 159.  
 
1.2.4 Ageing stroma 
 
Besides changes in the lymphoid compartment, the thymic stroma including thymic epithelium is 
subject to age-related alterations. These have been recognized in early studies with a description of 
functional consequences on T cell development 160. Morphologically, the most dramatic changes 
include shrinkage of cortical regions and disruption of the ordered architecture, which were irreversible 
upon transfer of BM from young mice 161 and thus imply a stromal cell-intrinsic defect. Multiple 
molecular changes were described in the stromal compartment derived from aged animals. Farr and 
Sidman demonstrate a prominent reduction of MHC II expression in particular in cortical TEC using 
immunohistological and biochemical means 162. Flowcytometric analysis furthermore reveals a 
decrease in the MHC IIhigh / MHC IIlow ratio with ageing 163,164. In addition, changes in TEC-associated 
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transcription factors and structural genes were found in relation to age 165. The most prominent 
decrease is shown for Foxn1 (which gradually declines after birth, see also reference 8), but reduced 
levels were also demonstrated for cytokeratin 8, a marker for cortical epithelium. The study by Yajima 
et al. suggests a role for Fas, expressed by the stromal compartment, in these age-induced changes of 
the epithelium 166.  
In addition to morphological changes, the proliferative potential of TEC declines with age 163, which is 
in close correlation with absolute TEC numbers. This seems to play a particular role in thymic 
involution as forced epithelial proliferation by means of transgenic overexpression of cyclin D1 
reversed this process 167, yet did not overcome thymocyte-dependent specification requirements of 
thymic epithelium168.  
However, ageing not only affects quantitative but also qualitative aspects of thymic stroma. Stromal-
derived factors such as SDF-1, IL-7, SCF, TSLP and TGFβ, which influence precursor recruitment as 
well as survival,  differentiation and apoptosis of thymocytes display age-dependent changes. 
Thymocyte development in old mice demonstrates a partial block in the transition from the DN1 to the 
DN2 stage 169, 170. This finding is concomitant with decreased level of the anti-apoptotic molecule bcl-2 
and increased apoptosis in DN2 and DN3 populations in aged mice. This is reminiscent of the situation 
observed in IL-7-deficient mice 171,172 and in line with the finding that IL-7 (but not SCF) could 
decrease the level of apoptosis in vitro and in vivo. In fact, mRNA levels of IL-7 in aged thymi are 
decreased in comparison to younger mice 173, 169. Transgenic overexpression of IL-7 within the thymus 
170 reverses the developmental block by increasing the local concentration of IL-7 in the thymus, yet 
without demonstrating an effect on thymic involution and furthermore uncovering an additional, IL-7-
independent proliferation deficiency at the DN4 stage. Nevertheless, in contrast with these studies is 
the finding of unaltered IL-7 levels in young and aged human thymi or thymi derived from myasthenia 
gravis patients 174. This however does not preclude changes in post-transcriptional events or in the 
efficiency of presentation of IL-7 by stromal cells 48.  
Elucidating the contribution of systemic administration of IL-7 to reverse thymic involution is 
complicated by the fact that IL-7 also affects the peripheral T cell pool 175,176. Additional cytokines and 
growth factors were assessed for their ability to influence thymic involution174, 142 and termed either 
‘thymostimulatory’ (s.a. IL-7, KGF, TSLP, hGH, GH secretagogue, Leptin, Ghrelin 177,178-181) 182. In 
fact, the level of thymopoiesis in human subjects of different age groups correlated indirectly with the 
expression levels of LIF, oncostatin, SCF, IL-6 and M-SCF 174. Administration of each of these factors 
to young Balb/c mice reduces thymic cellularity. In addition, transgenic over-expression of soluble LIF 
in T cells leads to a dramatic atrophy of the thymic cortex and severely perturbs the development and 
function of thymic epithelium 183.  
Age-dependent differences in thymic involution between BxD recombinant inbred mouse strains have 
stimulated the mapping of involution-associated quantitative trait loci 154,184,185, which suggest a 
contribution of IL-12 to thymic involution 185. In fact, inactivation of IL-12 enhances thymic 
involution, likely due to a proliferative deficiency of thymocytes, since IL-12 acts in concert with IL-2 
and Il-7 to enhance thymocyte proliferation.  
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Another molecule associated with increased thymic involution in studies of recombinant inbred strains 
was TGFβ. As homozygous inactivation of each of the three isoforms or their receptors leads to early 
(i.e. pre- or soon postnatal) lethality, these mice are not amenable to studies of thymic involution. 
However, earlier studies have shown an increase of TGFβ1 in the human thymus as a function of age 
174. TGFβ induces the thymosuppressive factors LIF and IL-6 in cultured human TEC186. Kumar et al. 
154 extend these findings using TGFβ2 heterozygous deficient mice, which show a delayed thymic 
involution, associated with increased numbers of LSK cells in the bone marrow and ETPs in the 
thymus of old mice. Despite a possible negative regulatory role of TGFβ2 on the lifespan and cycling 
potential of thymocyte precursor populations, an effect of TGFβ2 heterozygosity on stromal ageing is 
not excluded.  
 
1.2.5 The role of gonadal steroids in thymic involution 
 
The coincidence of the first, prominent phase of involution with puberty suggests that the increase in 
sex steroids in this period is instrumental in initiating and mediating the decline of thymic function. In 
mice, the reduction of thymic mass becomes visible as early as 6 weeks postnatal, concurrent with 
pubertal changes.  
Indeed, it was perceived a long time ago, even before J. Henderson 187 published his findings about 
thymic atrophy and its correlation with castration and pregnancy in cattle, that the thymic mass 
decreases with increasing age and that castration prevents such degeneration. This issue has found 
considerable interest in later studies in rats 188 and mice 189, showing the reversal of thymic involution 
as well as restoration of T cell function following removal of the gonads. Gonadal steroids replacement 
after castration rapidly re-induces thymic involution with a reduction in total thymic cellularity, a 
relative decrease in DP thymocytes and a corresponding increase in SP thymocytes 189. The increased 
levels of androgen receptors (AR) in TEC relative to thymocytes propose a mechanism via alteration of 
TEC function 190. Indeed, bone marrow chimeric mice using AR-deficient bone marrow transferred into 
castrated wildtype animals demonstrate a reduction of thymic cellularity upon challenge with 
dihydrotestosterone (DHT), whereas the opposite bone marrow chimeric combination was protected 
from these changes191. Nevertheless, minor direct effects cannot be ruled out completely 192. 
Interestingly, fetal thymi are protected from sex steroid-induced but not corticosteroid-mediated 
alterations. Indeed, mRNA levels of estrogen- and androgen-receptors are undetectable in fetal and 
neonatal thymi up to two weeks of age 193.  
Whereas the short-term effects of sex steroid ablation on thymic regeneration and T cell output are 
remarkable and have led to promising results in different settings (see below), long-term studies 
addressing the effect on the protracted phase of involution are scarce.  
A recent study by Min et al 194 re-evaluates the role of growth hormone (GH) and sex steroids in 
inducing thymic involution. The levels of GH and its major effector molecule IGF-I decline gradually 
with age. The prediction that the GH/IGF-I axis positively influences thymic cellularity was tested 
using the lit strain of mice (GH and IGF-I levels drastically reduced) and hpg mice, bearing a mutation 
in the GnRH gene, which results in gonadal atrophy and diminished sex steroid production. Neither of 
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these mice show a pronounced resp. delayed thymic involution, thus making a unique and lasting effect 
of these hormones on thymic regeneration unlikely. In addition, the effect of castration on thymic 
recovery is only transient, as 5 months after removal of the gonads thymic cellularity was equal to 
untreated animals and thymic involution proceeded unhindered.  
Nevertheless, ablation of sex steroids has proven to be very efficient in enhancing immune 
reconstitution after myeloablation and stem cell transplantation 195,196.  
 
1.2.5.1 Androgen-regulated cytokines 
 
Despite the large amount of information on the cellular effects of sex steroids, relatively little is known 
about the mechanism and the mediators leading to steroid-induced thymic involution. A potential 
mechanism how androgens inhibit thymopoiesis is via the repression of cytokines or their cellular 
source, which stimulate T cell development (such as IL-7), or on the other hand via the induction of 
repressive cytokines such as TGFβ. Interestingly, surgical castration results in a significant decrease of 
TGFβ mRNA levels produced by thymic stroma, whereas the levels of IL-7, KGF and SCF remained 
largely unaffected 196. Olson et al. furthermore demonstrate that castration reduces the levels of TGFβ1 
protein in the thymus whereas testosterone replacement leads to an increase in TGFβ1 mRNA levels 
and protein activity in thymi of castrated animals 197. The functional consequence of this increase in 
TGFβ1 activity on any thymic compartment was however not further investigated.  
Yet, other organ systems were explored for such effects. For example, bone marrow stromal cell-
derived TGFβ is responsible for the androgen-induced inhibitory effect on B cell development in co-
cultures of B cell precursors with stromal cells, whereas precursor cells alone show unhindered colony-
forming capacity 198. In addition, androgens positively regulate TGFβ1 transcription via direct 
activation of its promoter in human hepatoma cells 199.  
 
 
1.3 Irradiation damage to the thymus 
 
The relevance of the post-adolescent thymus was neglected for a long time, as the thymus was believed 
to gradually degenerate and loose its function. However, functional thymic tissue can be detected even 
in elderly individuals, showing essentially normal distribution of thymocyte subsets 200, 141, which 
indicates that the thymus retains its capacity to generate appropriately selected T cells throughout 
lifetime 161. T cell output from the thymus shows a remarkable linearity to the amount of thymic tissue 
141, 201, 174. Nevertheless, whereas in a young organism the thymus readily increases de novo production 
of T cells upon peripheral lympho-depletion, the ability of the aged thymus to increase thymic output 
in response to a sudden loss of peripheral T cells is greatly impaired. This is of particular importance in 
the setting of stem cell transplantation (HSCT) following myeloablation, where rapid regeneration of T 
cells is crucial for host immunity.  This is primarily established through peripheral expansion of graft-
derived T cells with an oligoclonal TCR repertoire.  However, T cells generated de novo in the thymus 
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will provide the host with appropriately selected T cells displaying a broad repertoire of TCR 
specificities 202-207. 
Thymic cellularity is dramatically affected by lethal irradiation, showing a rapid decrease within 24 
hours after irradiation in particular due to massive apoptosis of DP thymocytes 208-210, leaving a 
collapsed cortical region. A direct injurious effect of irradiation on the reconstitution potential of 
thymocyte-depleted thymic stroma was demonstrated 211. Non-irradiated thymic grafts transplanted 
after irradiation of the host demonstrate enhanced growth characteristics and peripheral T cell 
reconstitution in comparison to thymi implanted immediately prior to irradiation. This is accompanied 
by striking alterations in the non-lymphoid and in particular in the epithelial compartment, reversible 
within a week post-irradiation 212. Following exposure to ionizing radiation, TEC rapidly acquire a 
CK5+CK8+ double-positive phenotype, and up-regulate the expression of p63, c-myc and Tcf3, which 
normalize after reconstitution 213. Whereas low-level doses of γ-irradiation lead to increased thymic 
production of IL-7, SDF-1 and TECK 214, lethal doses augments the loss of TEC and thymic IL-7 
expression, which is reflected by a reduction in thymic cellularity 4 weeks after irradiation and 
reconstitution 215. In addition to direct cytotoxicity mediated by γ-irradiation with regards to  TEC 
survival,  ionizing radiation triggers the production or release of ‘thymoinhibitory’ cytokines. Indeed, 
apoptotic thymocytes – either treated with dexamethasone or γ-irradiation – release prestored TGFβ, 
which contributes to an immunosuppressive milieu 216. However, evidence for a specific role for TGFβ 
in thymic reconstitution is still lacking, though – as mentioned previously – TGFβ was shown to 
indirectly influence the proliferation of human 217 and mouse cells of the hematopoietic lineage, 
through down-modulation of stromal IL-7 production197,198. 
 
With respect to the focus of this study follows an introduction about the general role of TGFβ and 
downstream molecules involved in signal transduction, regulation and effector functions, followed by a 
summary of the current knowledge about the specific function of TGFβ in the thymic environment.  
 
1.4 The TGFβ family 218, 219 
 
Among the molecules involved in regulating cellular proliferation, differentiation, metabolism and 
apoptosis, the transforming growth factor-β family is of outstanding importance. Besides TGFβ, its 
members include activins, bone morphogenic proteins (BMP), myostatin, nodals, growth and 
differentiation factor (GFD)-8 and anti-Muellerian hormone (AMH). Whereas TGFβ shows a broad 
expression pattern, some of the other members are highly restricted to specific cell types. Alone or in 
concerted action they control cell division, differentiation and organization, adhesion and migration as 
well as homeostatic cell death and therefore play non-redundant functions in many biological processes 
from embryogenesis to immunity but have also been implicated in a multitude of pathological states 
including skeletal dysfunction, renal disease, fibrotic disorders, autoimmunity and tumorigenesis 
(reviewed in 220, 218, 219, 221-224). Potential interference of dysregulated signaling pathways using 
specific inhibitors reveals an emerging therapeutic field 225.   
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1.4.1 TGFβ isoforms 226 
 
In mammals TGFβ comes in 3 different, highly homologous isoform, termed TGFβ1 (19q13), 2 (1q41) 
and 3 (14q24) with the chromosomal localization in humans in shown brackets. The high homology 
between the isoforms is in marked contrast with the highly diverse phenotypes of the respective 
knockout mice. Different transcriptional and post-transcriptional regulation, resulting in non-
overlapping expression and specific up-regulation under physiological and pathological conditions 
account for these differences.  
In the embryo, the three isoforms show distinct expression patterns measured by in situ hybridization, 
whereby only TGFβ1 was clearly detected in the thymus as early as E12 227,228. Though the signal is 
dispersed throughout the thymic organoid at E12, expression seems enhanced within the lymphoid 
compartment 237. The role of TGFβ during embryonic development was analysed using knockout mice 
for all three isoforms. Mice deficient for TGFβ1 survive the postnatal period and show no overt signs 
of organ malformation or dysfunction. Yet, after weaning they rapidly succumb to a massive auto-
inflammatory pathology with expansion and activation of T cells, production of large amounts of pro-
inflammatory cytokines and infiltration of inflammatory cells into multiple organs 229. Analysis of the 
contribution of TGFβ1 to organogenesis is however complicated by the pre- and postnatal transfer of 
significant amounts of TGFβ1 from heterozygous mothers to their TGFβ1-deficient offspring via 
placenta and milk 230. This vertical transfer of TGFβ1 limits the analysis of detailed contributions of 
TGFβ1 to embryo- and organogenesis. Cardiac abnormalities comprising valve malformation, 
ventricular hypertrophy with disorganized proliferation of cardiomyocytes was detected in TGFβ1-/- 
pups born to a TGFβ1-deficient mother 230.  
In contrast to the mild phenotype of TGFβ1-null pups, deficiency for TGFβ2 results in early postnatal 
mortality due to a multitude of skeletal and organ malformations, in particular concerning lung, heart, 
inner ear and eyes as well as the urogenital tract 231. Yet, defects in the lymphohematopoietic system 
have not been described, though a correlation between thymic involution and responsiveness of LSK 
cells to TGFβ2 was described (see section on ‘thymic stroma’). Besides defects in palate fusion mice 
lacking functional TGFβ3 display no overt phenotype 232. Interestingly, TGFβ2-/- TGFβ3-/- double 
knockout mice die during mid-gestation and show severe midline fusion defects, indicating a certain 
redundancy between the different isoform, which is consistent with the partial overlap found in 
expression studies 233.  
The bioactivity of TGFβ isoforms is tightly controlled by several mechanisms (reviewed in 226). They 
are encoded as precursor proteins, proteolytically cleaved into the carboxy-terminal mature TGFβ (112 
AA) and the ‘latency associated peptide’ (LAP, 100kDa), which then associates with the mature form 
to mask its binding domain. Formation of this complex is required for secretion, which occurs as a 
complex of LAP with the latent TGFβ binding protein (LTBP, 220kDa). LTB proteins stabilize latent 
TGFβ and anchor it to the extracellular matrix. Association of TGFβ with either of these proteins 
specifies the trafficking, localization and rate of release of the cytokine. Harsh physical conditions such 
as high temperature or extremes of pH denature LAP, whereas TGFβ itself remains intact. Under 
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physiological situations, proteases such as plasmin, thrombospondin-1, reactive oxygen species, and 
conformational changes of LAP induced by binding to extracellular matrix or immunoglobulin, initiate 
the release of active TGFβ. The integrins αvβ6 and αvβ8 interact with the amino acid sequence 
arginine-glycine-aspartic acid (RGD) near the C terminus of TGFβ-LAP, which releases active TGFβ 
possibly through conformational change of the LAP. A role for mechanical stress in the integrin-
mediated activation of matrix-associated TGFβ by myofibroblasts was recently demonstrated 234. Mice, 
in which systemic or conditional inactivation of these integrins or the RGD in the LAP sequence was 
achieved, recapitulate phenotypic characteristics observed in the absence of TGFβ signaling and 
demonstrate the importance of this interaction for the local control of TGFβ activity 235-237. This is of 
particular relevance in the context of vasculogenesis, immune tolerance  as well as for the formation of 
Langerhans cells 238,239. External physical stimuli, such as injury or ionizing radiation also contribute to 
the activation of TGFβ from extracellular deposits 240,241, which has implications with respect to 
fibrotic processes or scar formation 242,243. 
 
1.4.2 The signaling components 
 
TGFβ utilizes several signaling pathways, whereby the best-studied, termed the canonical pathway, 
involves Smad molecules for transcriptional activation.  
The sensing of TGFβ signals by a specific cell involves multiple steps. Homodimers of TGFβ1 or 3 
directly bind to TGFβ receptor type II (TbRII), which is a constitutively active serine/threonine kinase. 
Cytokine binding allows for bi-dimeric complex formation of the type II receptor with the TGFβR I 
(TbRI, a.k.a. Alk5), which results in the phosphorylation of serine and threonine residues in the GS 
region – a regulatory region characteristic of type I receptors, sitting immediately upstream of the 
kinase domain. This phosphorylation leads to the release of the inhibitory factor FKBP12 from this 
region, allowing the binding of transcription factors of the Smad family.  
In mammals, seven type I receptors, which are referred to as activin receptor-like kinases (ALK1-7), 
and 5 type II receptors (ActR-IIA, ActR-IIB, BMPR-II, AMHR-II and TbR-II) have been identified. In 
the case of TGFβ signaling the involvement of at least four different receptors was demonstrated 
(reviewed in 219) with TbRI (53kDa) and TbRII (70kDa) being presumably the main components for 
initiating TGFβ signaling. TbRIII (a.k.a. betaglycan) serves as an accessory receptor presenting TGFβ 
to TbRII, thus positively but also negatively influencing the activation of the cascade in a cell type-
specific manner 244. TbRIV was described in a rat cell line, but its identity and function remain to be 
further defined 245. The TbRV is co-expressed with TbRI, II and III and in addition to enhancing TGFβ 
signaling is mediating IGFBP-3 signaling 246. 
 
1.4.2.1 Smad proteins 247 
 
Intracellular key molecules of the canonical pathway, integrating and relaying signals of TGFβ are 
comprised of Smad molecules. Out of the eight Smad proteins encoded in the human and mouse 
genome, five – termed receptor-regulated (R-Smads) – serve as substrates for the serine/threonine 
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kinases of the type I receptors. Whereas Smad 1, 5 and 8 are utilized to transmit BMP and AMH 
signals, Smad2 and 3 mediate activin, TGFβ, and nodal signals.  
Regulatory elements within the Smad family include Smad4 – a common partner to all R-Smads and 
therefore named Co-Smad – and the inhibitory factors Smad6 and 7. R-Smads consist of a N-terminal 
Mad homology (MH) 1 domain, required for nuclear translocation and DNA-binding activity, which is 
connected with a flexible linker region to an MH2 domain. The latter interacts with a multitude of other 
components such as the receptor, nucleoporins, partner Smads and other nuclear regulatory factors and 
thus controls cytoplasmic retention, activation, nucleocytoplasmic shuttling and gene transcription248. 
The receptor-associated Smad2 and 3 proteins are phosphorylated at the carboxy-terminal Ser-Xxx-Ser 
motif by the TbRI serine/threonine kinase. The interaction between between the activated receptor 
complex and R-Smads is greatly facilitated by Smad Anchor for Receptor Activation (SARA), a 
cytoplasmic protein, localizing non-phosphorylated Smad2 in close proximity to TbRI kinases 249. 
Further adaptor molecules such as Axin or disabled 2 (Dab2) stabilize the receptor-Co-Smad complex 
(reviewed in 248). Subsequent phosphorylation leads to the formation of an active complex with the 
Co-Smad4, allowing nuclear accumulation of the R-Smads inducing transcription of target genes. In 
addition, Smad2-phosphorylation and nuclear translocation occurs without direct association with the 
TbRI and independent of the Ser-Xxx-Ser motif, through interaction with activated MAPK/Erk kinase 
kinase 1 (MEKK1) 250. In a complex with other factors (in particular p300 or CBP) R-Smads regulate 
the level of transcription of TGFβ target genes. This seemingly simple and linear signaling pathway of 
TGFb gains a high level of complexity by input on several levels. The integration of the binary input 
signal into a cellular response varies greatly between different cell types, which forces studies of the 
cellular context. As DNA-binding of the MH1 domain of R-Smads is relatively weak, high specificity 
of transcription is achieved through a complex array of cell type- and context-specific transcriptional 
regulators and co-factors, of which further details and additional components are just emerging. An 
immediate gene response mediated via pre-existing co-factors versus late gene responses due to 
induced expression of co-factors has to be distinguished. Similar gene responses shared by different 
TGFβ family members due to usage of the same intracellular signaling molecules are referred to as 
synexpression groups, characterized by rapid activation and repression of hundreds of genes.  
 
1.4.2.2 Regulation of Smad-mediated signaling 
 
These growth and differentiation factors are subjected to tight regulation at different levels, either 
directly through expression, compartmentalization, modification and degradation of signaling 
components of indirectly via modification of the signal through co-factors. Receptor elimination from 
the cell surface is achieved via endosomal internalization. This compartimentalization of activated 
receptor-ligand complexes in endosomes furthermore enhances signaling through more efficient R-
Smad recruitment, followed by receptor degradation. The expression of R-Smads and Smad4 underly 
temporo-spatial regulation during embryonic development 251 but are widely and constitutively 
expressed in the adult organism 252. Compartmentalization of Smads through their association with 
cytoskeletal components such as microtubules reduces the proportion of protein available for 
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phosphorylation. Protein degradation is regulated by Smad-ubiquitination-regulatory factors (Smurf-) 1 
and 2 253. Nuclear importation requires the conformational changes induced by C-terminal 
phosphorylation of the MH2-domain. The nuclear environment contains constant phosphatase activity. 
Dephosphorylated and thus inactivated Smads are rapidly exported from the nucleus. Input from 
signaling molecules other than TGFβ family members (such as HGF or EGF) can negatively influence 
the nuclear accumulation of R-Smads through phosphorylation of their linker region254. In contrast to 
R-Smads, inhibitory Smads 6 and 7 show a tightly controlled expression pattern. Smad7, which 
negatively regulates TGFβ-signaling, is induced by TGFβ itself, down-modulating the signal activity in 
a negative feedback loop 255. The same mechanism is found for Smad6 in the BMP signaling pathway 
256. Smad7 associates in a complex with Smurf2, which is as a consequenc exported from the nucleus 
and associates with the activated TGFβR-complex. This leads to upiquitination and degradation of the 
activated receptors 257,258. In addition, Smad7 nuclear export is induced rapidly after TGFβ stimulation 
and the MH2 domain of Smad7 binds to the type I receptor competitively preventing the association 
thereof with R-Smads. Interestingly, besides its inhibitory activity on Smad-mediated signaling, Smad7 
itself is able to induce transcription of target genes, however cellular effects remains to be clarified 259. 
In addition to these regulatory mechanisms, distinct pathways were shown to interact with the TGFβ-
signaling cascade. Phosphorylation of Smad3 in response to TGFβ stimulation is negatively influenced 
by Jak1-STAT1-mediated IFN−γ signaling through the induction of Smad7 260. In addition, other pro-
inflammatory cytokines, such as IL-1b and TNF-α up-regulate Smad7 via activated NF-κB signaling 
261. A further mechanism of negatively regulating the transcriptional activity of Smads is the 
phosphorylation of the linker region, containing Ser-Pro and Thr-Pro, by MAPKK, CamKII and CDK, 
which hinders nuclear accumulation and transcriptional activity or promotes ‘enucleation’ of Smads.  
 
1.4.2.3 Transcriptional regulation 
 
Depending on the recruited co-factors Smad complexes can both activate and repress transcription. 
CBP and p300 are of prime importance for DNA-binding in Smad-induced transcription 262, as R-
Smads themselves (with the exception of Smad2) show a relatively weak DNA-binding activity, 
contained in the MH1 domain and  restricted to Smad-binding elements (SBE). Despite its weakness, 
this interaction is nevertheless required for transcriptional activation. Smad4 stabilizes the complex 
formed by R-Smads, CPB/p300 and DNA. Transcriptional co-repressors include TGIF 263, Ski, SnoN 
264and Snip1. They assemble with the Smad/CBP/p300/DNA complex and with histone deacetylases. 
The relative protein levels of co-repressors and –activators determines the overall transcriptional 
response of the cell 263. 
Enhancement of SnoN and Ski degradation by TGFβ in a Smad-dependent manner - thus reducing its 
own co-repressor - leads to immediate de-repression of TGFβ-signaling 265, which was recognized as a 
general early response of a multitude of cell types in response to TGFβ, whereas a delayed up-
regulation of Ski provides feedback inhibition of the pathway.  
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1.4.2.4 Smad-independent TGFβ-signaling 
 
Besides Co-Smad-independent signaling induced by Smad2/3-TIF1γ complexes, which regulate 
effector functions complementary to Smad2/3-Smad4 activity267, it was recently appreciated that TGFβ 
can induce a cellular response even in the complete absence of Smad-phosphorylation 252. Yu et al. 
were able to relate cellular responses to the different signaling pathways 268, demonstrating an absolute 
requirement for p38 MAPK activation in TGFβ-induced apoptosis and epithelial-to-mesenchymal 
transition (EMT), whereas R-Smads are required for EMT and independently regulate growth arrest. 
Other pathways, which are activated by TGFβ, include furthermore PI3 kinases, Rho family members 
and JNK. Yet, the links between the surface receptor and the activation of the kinases is to date largely 
unknown.  
 
1.4.3 Cellular effects of TGFβ  
 
1.4.3.1 General principles 
 
Cellular effects regulated by TGFβ isoforms are cell proliferation, apoptosis and differentiation and 
extracellular matrix (ECM) production. TGFβ was primarily recognized as a growth inhibitory factor 
of most cell types (in particular epithelia) with the exception of mesenchymal cells 219. Cell cycle arrest 
– in particular at the G1 to S phase transition – is achieved through transcriptional repression of c-myc, 
Id1-3, and cyclin-dependent kinases (CDK) as well as induction of CDK inhibitors such as p15 and 
p21 252. Induction or suppression of programmed cell death by TGFβ shows great variability between 
different cell types and only few of the key molecules have been identified to date. Epithelia can 
undergo apoptosis involving the TGFβ-inducible early-response gene (TIEG1) 271. Smad-dependent 
upregulation of death-associated proteinkinase (DAPK) and SH2-domain-containing inositol-5-
phosphatase (SHIP) in hepatocytes and hematopoietic cells, respectively, sensitizes these cells to 
apoptotic stimuli. Downstream molecules of the apoptotic pathway include bcl family members and 
effector caspases, which might themselves be subjected to regulation by TGFβ 272.  
The most fascinating aspect of TGFβ family members might be their role in regulating self-renewal, 
lineage selection and differentiation into specific cell types, which is most prominent during embryonic 
development 273. I will focus on the effects of TGFβ on thymocyte development.  
 
 
1.4.3.2 TGFβ and thymocyte development   
 
Early studies demonstrated an inhibitory role of TGFβ on IL-1-, PHA- or ConA-induced proliferation 
of thymocyte bulk cultures, in parts reversible by IL-2 274,275, whereas IL-7-induced thymocyte 
proliferation was less susceptible to inhibition by TGFβ 276. TGFβ stimulated the differentiation of 
CD8+CD3- cells from CD25+ CD4-CD8- cells 277, possibly representing intermediate single positive 
(ISP) thymocytes 278. TGFβ is expressed by thymic epithelium in the outer cortex and inhibits cell 
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cycling of ISP as well as their progression to DP thymocytes 279. Addition of TGFβ1 and -2 to fetal 
thymic organ cultures (FTOC) led to a partial block at the TN1 stage, reduced total cell recovery in a 
dose-dependent manner, affecting all cell populations with the notable exception of CD3+ SP8 280. 
Using human thymocytes in an in vitro system, Mossalayi et al. demonstrate a role for CD3+CD8+ 
thymocytes in the activation of TGFβ produced by TN cells, which in turn led to the inhibition of 
cytokine-induced TN proliferation 281.   
Mice deficient for genes of the ligands or their receptors allowed studies of the in vivo role of TGFβ.  
Whereas the lack of TGFβ2 and -3 did affect proper formation of different organs and palate fusion 
respectively (see section 1.4.1), a regulatory function of TGFβ1 on peripheral T cell function was 
suspected, as corresponding knockout animals die due to a severe autoinflammatory disease a few 
weeks after birth 229,231,232. These mice demonstrate increased levels of pro-inflammatory cytokines 
such as IFN-γ, TNF-α, IL-1β and MIP-1α in infiltrated organs 229. Interestingly, prior to development 
of disease i.e. prenatally and in the second week of life, these mice show a significant decrease of 
thymic cellularity with enhanced thymocyte apoptosis, whereby inflammatory cytokines as possible 
factor could be excluded. A potential explanation was sought in a disturbed mitochondrial structure and 
membrane potential, as TGFβ1 co-localized with mitochondrial proteins. In addition, peripheral T cells 
showed increased susceptibility to apoptotic stimuli due to up-regulated pro-apoptotic signaling 
molecules (Fas-FasL, TRAIL, TNFR), which was however not demonstrated for thymocytes. This 
inclination for cell death was not reversible through the addition of exogenous TGFβ1 and was not 
seen in Smad-deficient T cells 282. On the other hand, reports about development of thymocytes 
deficient in TGFβ-signaling are conflicting. TGFβRI and II-deficient animals die in midgestation (with 
no live embryos retrieved by E11) due to severe endothelial dysfunction and defects in vasculogenesis 
in the yolk sac and the embryo proper, and are therefore not amenable to thymic analysis. Erythroid 
and myeloid potential was intact in TGFbRI knockout precursors 283, which was confirmed using 
conditional inactivation in hematopoietic cells 284. T cell development in the thymus was studied using 
conditional ablation of TGFβ-signaling by either expression of a dominant-negative TGFβRII (lacking 
signaling activity) directed to T cells (under the control of the murine CD4 promoter 285 or the human 
CD2 promoter/enhancer 286) or by conditional ablation of TGFβRII expression (using Mx-Cre 287 or 
CD4-Cre mice 288,289).   
Yet, the role of TGFβ on thymic epithelial development in vivo has not been addressed.  
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2 Aim of the Thesis 
 
The aim of this thesis is to elucidate the role of TGFβ-signaling in thymic epithelial cells in (A) their 
phenotypic development, (B) their potential to support thymopoiesis under steady-state conditions, (C) 
their involution and (D) their capability for self-regeneration and reconstitution of the T cell 
compartment myeloablative conditioning. 
To this end, conditional inactivation of the TGFβRII specifically in thymic epithelium was applied. 
Furthermore, mice with inactived Ski – a negative regulator of TGFβ-signaling were analysed.  
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3  Results  
 
3.1 TGFβ1-3 and the corresponding receptors are expressed in the area of the prospective 
thymus 
 
The ventral aspect endodermal lining of the 3rd pharyngeal pouch on embryonic day (E)10.25 contains 
the precursor cells, that will give rise to the thymic epithelial compartment. In an attempt to uncover 
factors contributing to early thymic organogenesis, using laser capture microdissection this area was 
subjected to microarray analysis comparing the expression levels either to the dorsal region or the 
adjacent pouches. In the resulting screen TGFβ family members and the matching receptors as well as 
downstream molecules showed significant expression (Table 1 and K. Na, Y. Mathieu, G.A. Holländer, 
unpublished observations). Table 1 shows a summary of data obtained from microarray analysis of the 
3rd pharyngeal pouch, as well as from semi-quantitative RT-PCR analysis of TEC at different stages of 
development and in the adult. In addition, the expression for TGFbRI and II are shown for the cortical 
and medullary thymic epithelial cell lines, established from neonatal C57Bl/6 mice as previously 
described 290,291.  
 
3.2 Expression and protein levels of TGFβ in the adult thymus   
 
Transcript levels for TGFβ isoforms were determined in whole adult thymi derived from C57Bl/6 mice 
at different ages (2, 5, and 24 months). Whereas only slight and transient increases in TGFβ1 levels 
over time were observed, TGFβ2 levels showed a steady increase with increasing age. As TGFβ is 
subject to a multitude of posttranscriptional and –translational changes, protein levels were determined 
in the very same thymi using an antibody detecting TGFβ1, -2, and -3 (clone 1D11). Figure 1B shows a 
striking, age-related increase of TGFβ protein in these thymi. In an attempt to identify the cell-type 
involved in the production of TGFβ, different thymocyte (Figure 1C upper panels) and stromal (Figure 
1C, lower panel) subpopulation were subjected to intracellular staining for TGFβ1-3, demonstrating 
significant fractions of positively staining cells in the DN as well as in stromal fractions.  
 
3.3 Thymic epithelial cell lines respond to human TGFβ1   
 
Canonical TGFβ-signaling leads to rapid phosphorylation of Smad2. To measure the kinetics of Smad2 
phosphorylation in the cortical TEC line TEC1.2, the cells were exposed to 10ng/ml TGFb1 and 
harvested at different time points thereafter. The left panel of Figure 2A shows a rapid phosphorylation 
of Smad2 within 15 minutes post-exposure which slowly declines over ≥ 1 hr. In addition, staining of 
fixed TEC1.2 cells for total Smad2 using a monoclonal antibody revealed that within 30 minutes post-
exposure most of the cellular Smad2 translocates to the nucleus, whereas in unstimulated cells the 
majority of the protein localized to the cytoplasm (Figure 2A, right panel).  
To investigate the cellular consequences of TGFβ1 on TECs, 1.5x105 cells of different TEC lines were 
exposed to 10ng/ml human TGFβ1 for 48 hrs. One out of two similar experiments are presented. All of 
the analyzed cell lines – cortical as well as medullary – show reduced cell number after 48 hours 
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(Figure 2B) in the presence of the cytokine, however it only reaches statistical significance in the 
medullary TEC lines 2.3 and C6. To identify whether the reduced cell recovery is due to reduced cell 
proliferation or an increase in apoptosis or a combination thereof, the cells were again grown in the 
presence or absence of 10ng/ml human TGFβ1, and either pulsed with 3H-thymidine for the last 16 
hours prior to harvest or prepared for cell cycle analysis. Figure 2C shows the quantification of 3H-
thymidine incorporation, which is drastically reduced in the medullary TEC 2.3 and C6 and to a lesser 
extent in the cortical lines 1.2 and 1.4. This is consistent with a reduction of cells in G2/S phase from 
13% (TEC 1.2) up to 56% (TEC C6) (data not shown). To discover whether TGFβ1 did induce 
apoptosis in these cells, they were stained with fluorochrome-labeled AnnexinV, which binds to 
phosphatidylserine residues in the outer membrane of apoptotic cells, and analyzed by flow cytometry. 
Dead cells – measured by their incapacity to exclude propidium iodide – were electronically gated out. 
The cortical TEC1.4 and the medullary TECC6 did show a significant increase in the apoptotic fraction 
(Figure 2D).  
As TGFβ1 is known to induce several cyclin-dependent kinase inhibitors (CKIs) and to repress c-myc 
in a Smad3 dependent manner, transcriptional changes of these genes in the thymic epithelial cell line 
TEC1.2 in the presence or absence of TGFβ were assessed. The cells were cultured for 48hrs in the 
presence or absence of purified hTGFβ1 (10ng/ml) and subsequently analysed for transcriptional 
changes in the genes indicated in Figure 2E, demonstrating a down-regulation of c-myc and cell-cycle 
regulators, whereas p53 is up-regulated.  
 
3.4 Effects of TGFβ1 on primary TEC in d-Guo depleted FTOC 
 
To assess the effect of TGFβ1 on cellularity of primary TEC, independent of thymocyte-mediated 
effects, E15 fetal thymi were depleted of thymocytes using d-Guo for 7 days, washed in medium and 
exposed to 20ng/ml hTGFβ1 or culture medium for 40 hours. Thereafter, triplicates of pooled thymic 
lobes (10 each) were assessed for total cellularity, expression of MHC II (I-Ab), E-cadherin and 
ICAM-1 as well as Ki-67 antigen. Treatment with TGFβ1 significantly decreased total cellularity, in 
particular due to a significant reduction in EpCAM+ I-Abhigh cells, whereas the remaining CD45+ as 
well as the CD45- EpCAM+ I-Ablow cells were not significantly affected (Figure 3A).  
Measuring Ki-67+ cells by flow cytometry revealed a significantly decreased proportion and absolute 
numbers of proliferating epithelial cells in TGFβ1-treated FTOC (Figure 3B). Again, proliferation of 
non-epithelial stroma was not significantly affected by the presence of TGFβ (data not shown). 
 
3.5 Conditional ablation of TGFβRII specifically in thymic epithelium 
 
Mice with a TEC-specific deletion of Smad4 display a dramatic reduction in thymic size, reduced 
numbers of ETP and pronounced thymic involution 292. These results in conjunction with the 
aforementioned results prompted us to further investigate the involvement of TGFβ in TEC 
development and differentiation. To address this issue we wished to conditionally ablate a crucial 
component of the TGFβ signaling pathway within the developing TEC. However, to ensure adequate 
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specificity for TGFβ this element was required to be as far up-stream as possible in the signaling 
cascade, at best involved in ligand binding. As the TGFβ receptor type II (TGFβRII) constitutes a non-
redundant component of the TGFβ -binding and -signaling complex it seemed an ideal target for our 
studies. The crucial contribution of the type II receptor to normal development was demonstrated from 
studies of TGFβRII knockout mice, which do not survive past E10.5 due to severe developmental 
defects, thus precluding the study of thymus development in these mice. Nevertheless, the availability 
of mice bearing alleles with a floxed exon of this receptor gave us the opportunity to study the effects 
of its conditional deletion specifically in thymic epithelial cells. This would also give us the 
opportunity to investigate FTOC in the presence of TGFβ to study its direct as well as indirect effects 
on thymocyte development via TEC. 
 
3.5.1 Characterization of recombination using Cre expression driven under the control of the 
Foxn1 promoter 
 
The transcription factor Foxn1 is specifically expressed in developing TEC during development, in a 
subpopulation thereof under steady-state conditions 8 as well as in precursor cells of the hair bulge. 
Mutations leading to inactivation of Foxn1 – first observed in the spontaneously appeared nude mice – 
arrests TEC differentiation at an early stage, which precludes immigration of thymocyte precursors into 
the rudiment and ultimately results in severe T cell immunodeficiency 6. Driving Cre expression under 
the control of the Foxn1 promotor therefore provides an elegant and convenient way of conditionally 
(i.e. specifically in thymic epithelium) ablating genes, that show otherwise early embryonic lethality in 
the context of germline deficiency. However, as Cre-mediated recombination is occurring with a 
certain delay with respect to Foxn1 promoter activation, we wished to get an insight into the kinetics 
and completeness of recombination. To this end, we bred the Foxn1-Cre mice to different indicator 
strains, whereby expression of Cre will lead to recombination of the target sequence and lead to 
expression of either eGFP or β-galactosidase specifically in these cells, allowing the visualization and 
quantification of recombination as measured by β-galactosidase activity or GFP fluorescence.  
Analysis of mice expressing the Cre recombinase and either LacZ under the ubiquitously expressed 
Rosa26 promoter or GFP driven by the chicken β-actin promoter, revealed Foxn1-Cre-mediated 
recombination (with subsequent β-galactosidase activity) as early as E12 in the thymic primordium 
(SZ, unpublished observation). By flowcytometric analysis of E15 embryos, eGFP expression was 
consistently detected in over 80% of thymic epithelial cells, a feature, which persisted until at least 4 
weeks after birth (Fig. 4A, upper panels). Thymocytes on the other hand did not express detectable 
eGFP levels (Fig. 4A, lower panels), consistent with the fact, that they do not express Foxn1 at any 
stage of their development.  
 
3.5.2 The Cre recombinase protein is barely detectable by flow cytometry in TEC from Foxn1-
Cre mice 
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Foxn1 expression was reported for thymic stroma in the adult mouse 165. Foxn1-promoter driven Cre 
expression measured on the protein level could be detected by flow cytometry in the adult animal (Fig. 
4B) only as a slight shift in a histogram of the MHC class IIhigh population (Figure 4B, left histogram), 
though not in MHC class IIintermediate cells (Figure 4B, right histogram). Thymic epithelial cells derived 
from a mouse expressing Cre protein under the promotor of the Autoimmune Regulator served as 
positive control for the staining and showed a intermediate expression levels of Cre protein in a 
subpopulation of MHC class IIhigh cells (Fig. 4B, right panel and N. Shikama-Dorn, unpublished 
observations), which is consistent with previously reported expression of Aire in a subpopulations of 
MHC class IIhigh cells.  
Whether the weak signal observed was due to low amount of protein produced or absent transcription 
or translation respectively has not been verified, and whether Cre protein is detectable at higher levels 
during embryonic stages remains to be tested.  
 
3.5.3 Hoxa3-Cre is active prior to Foxn1-Cre 
 
Induction of the thymic primordium is independent of Foxn1, concordant with the finding that 
expression of Foxn1 is first detected around E11.5 8. Cre expression driven under the Foxn1 promoter 
can therefore be expected around this developmental stage, whereas recombination and consecutively 
loss of transcription of the target gene will follow with a certain delay. Effect(s) of the loss of the 
protein would thereafter only be recognizable at a relatively late time point – probably within 24-48 hrs 
after expression of Foxn1 – depending on the half-life/turnover of the protein. As Foxn1 is itself not 
required for inductive events during thymic organogenesis 6. Therefore, the Foxn1-Cre mouse is not 
suitable to study these early events.  
To bypass the potential problem of conditionally ablating our gene of interest only late in development, 
we chose to make use of a knock-in mouse, expressing Cre under the control of the Hoxa3 locus 14. As 
published previously, Hoxa3-Cre expression is by no means restricted to thymic epithelium (Figure 
5A, top panel), as the GFP-reporter ::Hoxa3-Cre E10.25 embryo shows strong GFP expression 
downwards of the neck region, sparing the head. Analysis of crossings to the aforementioned reporter 
lines showed recombination as early as E10.25 in the pharyngeal region, with β-galactosidase activity 
detectable caudally from the second pouch (Figure 4A, middle and lower panel). In E14 and E19 
embryos as well as adults flowcytometric analysis revealed a strong GFP signal in literally all thymic 
cells of epithelial kind (Figure 5B, top panels) but only in a small fraction of hematopoietic (Figure 5B, 
middle panels) or non-epithelial stromal origin (Figure 5B, lower panels), disclosing a relatively high 
specificity of Hoxa3 expression for thymic epithelium. As conditional deletion of Smad4 in thymic 
epithelium using the Cre-recombinase driven under the Foxn1 promoter has dramatic effects on thymic 
cellularity and the phenotype of thymic epithelium we used this mouse as a ‘functional reporter’ to 
study whether Hoxa3-Cre-mediated deletion would result in a more severe phenotype. 
Smad4lox/lox::Hoxa3-Cre embryos died at E9.5 and only an unrecognizable mass could be recovered at 
E11.0 (Figure 5C, right panel). Despite the impracticality to retrieve a structure reminiscent of a 
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thymus, this was nevertheless important evidence for the ‘high fidelity’ of the Hoxa3-promoter driven 
Cre expression.  
 
3.5.4 Lefty-Cre is not useful for conditional inactivation of genes in mesenchymal cells 
 
Organogenesis in general involves the interaction of epithelial with mesenchymal cell types. The 
importance of mesenchyme as a support for the expansion – but not for the differentiation – of thymic 
epithelium during organ formation has been described 50,293. The idea of conditionally ablating genes in 
mesenchymal cells, supporting the developing TEC, was of particular interest, as this would reveal the 
contribution of identified factors on mesenchymal behaviour in situ [i.e. without removing the thymus 
from the developing organism]. To date no mesenchyme-specific promoter region has been identified, 
that would allow the specific and extensive (i.e. involving a high fraction of cells) recombination in 
stromal cells of mesenchymal origin surrounding the thymus. Cre recominase expression under the 
control of the lefty promoter, a mouse generated in A.Moons laboratory in Salt Lake City, was reported 
to show mesenchyme-specific expression (A.M., personal communication). To test the specificity of 
Cre expression this mouse was again crossed to the previously mentioned reporter strains. GFP was 
detected in the upper part of the embryo at E14 (Figure 6Ai). Yet, whereas a strong expression of β-
galactosidase activity was detected e.g. in the mesenchyme of the developing lung or in the heart, no 
such expression was detected in peri-thymic or thymic mesenchyme (Figure 6Aii-iv) in E14 embryos. 
In E17 thymi only a fraction of endothelial cells revealed expression of the enzyme (Figure 6B, upper 
and lower panel), whereas in thymi from newborn mice also cells in subcortical areas indicated 
expression (Figure 6Ci, ii). Furthermore, flowcytometric analysis of adult thymic tissue demonstrated 
recombination not only in a small fraction of mesenchymal cells (ERTR7+, CD31+) but also in a 
minority of HSC-derived cells (thymocytes, CD11b, CD11c, CD11b/c) (Figure 6Ci-iv), making the use 
of this mouse unsuitable for further studies.  
 
3.6 Conditional ablation of TGFβRII 
 
Mice carrying floxed alleles of the TGFb receptor type II – hereafter described as TGFbRIIlox/lox were 
generated in different laboratories. We obtained the mice bearing a LoxP-sites flanked exon 3 of the 
TGFbRII as a kind gift of Dr. J. Roes, London. Cre-mediated recombination results in direct splicing of 
exon 2 to exon 4, which creates a frameshift mutation generating a stop codon. Translation therefore 
terminates before the transmembrane domain with complete loss of functional receptor activity 294.  
 
3.6.1 TGFbRIIlox/lox-Foxn1::Cre mice are viable, fertile and show no macroscopical changes of 
epidermal appendages 
 
The offspring of the crossing TGFβRIIlox/lox::Foxn1-Cre x TGFβRIIlox/lox showed a mendelian 
distribution of genotypes, with 191 (50.1%) of animals expressing Cre recombinase of 381 animals 
analysed (Figure 7A). Cre positive mice showed normal viability (up to 72 weeks observed) and 
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fertility. Foxn1-Cre activity was tested on resting as well as on branching and differentiating mammary 
glands during pregnancy using the Rosa26-lacZ reporter strain. Whereas no or very little β-
galactosidase activity was detected in mammary glands derived from nulliparous adult Rosa26-
lacZ::Foxn1-Cre positive female mice, branching epithelia showed intense substrate deposition (data 
not shown). It was therefore of interest, whether TGFβRIIlox/lox::Foxn1-Cre mothers were able to 
sufficiently lactate in order to sustain normal litter sizes. Indeed, litter sizes until weaning were 
comparable to Cre negative females.  
Foxn1 expression was furthermore reported for the matrix, cortex and outer root sheet of the hair 
during the anagen phase and the nail forming regions with a role in inducing keratin expression 10. 
Superficial layers of the adult skin revealed β-galactosidase activity in Rosa26-lacZ::Foxn1-Cre mice 
(data not shown). However, no macroscopically obvious defect of hair or nail development was 
discernible (data not shown).  
 
3.6.2 Hoxa3-Cre-mediated deletion of th floxed TGFβRII allele results in mid-gestational 
lethality 
 
In contrast to TGFβRIIlox/lox::Foxn1-Cre mice, Hoxa3-Cre expression in conjunction with two floxed 
alleles of the TGFβRII is embryonic lethal. A more careful analysis of genotypes at different 
embryonic stages revealed frequencies in accordance with Mendelian expectations in E12 or E13 
TGFβRIIlox/lox::Hoxa3-Cre embryos. However, E13 TGFβRIIlox/lox::Hoxa3-Cre embryos were slightly 
smaller and showed a delayed development (upper extremities, separation of fingers). On embryonic 
day 14 a smaller than expected ratio of embryos with the genotype of interest could be recovered 
(Figure 7B). These embryos showed furthermore a pronounced delay in development (smaller in size, 
delay in developmental milestones), a protrusion of the thinned frontal abdominal wall, and irregularly 
structured blood vessels, sometimes accompanied by hemorrhage. Intact thymic lobes could be 
recovered as late as E13.5 and used for further studies (see below). However the isolated lobes were 
usually smaller than those derived from their Cre- littermates. Thus, for transplantation experiments 
thymic lobes derived from E12.5 embryos were chosen. It is of interest to note that in the presence of 
Hoxa3-Cre expression one wildtype TGFβRII allele was sufficient to protect the developing embryo 
from these adverse effects.  
Genotyping adult offspring from TGFβRIIlox/wt::Hoxa3-Cre x TGFβRIIlox/lox breedings revealed that 
most mice devoid of the Cre knock-in were either homozygous for the floxed allele or heterozygous for 
the floxed and the wildtype allele. However, in some of the Cre negative offspring a deleted allele 
besides a wildtype or a floxed allele (see also Figure 9B) could be identified. This indicates that in 
TGFβRIIlox/wt::Hoxa3-Cre animals Cre-mediated recombination in germ cells can occur.  
 
3.6.3 TGFβRIIlox/lox::Foxn1-Cre mice display normal thymic migration and architecture  
 
Conditional deletion of the receptor in thymic epithelium showed no influence on migration of the 
developing thymus, as final positioning of the thymus, as exemplified in 3-week-old mice (Figure 8A) 
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was normal. Hematoxylin/Eosin staining of thymic sections of 3-week-old mice showed a clear 
distinction of cortex and medulla, typical for normal thymic tissue (Figure 8B). Confocal microscopy 
moreover revealed no evident differences between Cre positive or negative littermates in the frequency 
or distribution of ERTR7+ fibroblasts or distinct cortical or medullary TEC subpopulations, evaluated 
for expression of Keratin 5 (K5), Keratin 8 (K8) and UEA-1 30 (Figure 8C-F’) as demonstrated for 
young (i.e. 5 week old) mice.  
 
3.6.4 The floxed TGFβRII alleles are efficiently and specifically recombined in Foxn1-Cre 
expressing mice at embryonic day 14 
 
To verify, that Cre recombinase did specifically and efficiently excise the floxed alleles of TGFβRII, 
sort purified TEC and dendritic cells from individual mice were subjected to PCR analysis of the 
isolated genomic DNA. Purity of the obtained cell populations usually reached 93-95% for TEC and 
>95% for DC. Whereas no deletion could be detected in DC, TEC showed a high level of 
recombination on the DNA level (Figure 9A, left side). Nevertheless, a small band characteristic for the 
floxed allele was apparent. The same analysis was performed on sort-purified TEC and DC derived 
from TGFβRIIlox/del::Foxn1-Cre (i.e. crossed previously to a general deleter in order to obtain one 
deleted allele), which reduced the signal from the floxed band to barely detectable (Figure 9A, right 
side). In addition, sorted thymic epithelium (CD45- EpCAM+, purity >99%) from E14 thymic lobes 
was subjected to PCR of genomic DNA to examine deletion at this early time point. As shown in 
Figure 9B, roughly 103 TEC from TGFβRIIlox/lox::Foxn1-Cre mice showed a very high level of deletion 
of the floxed alleles of TGFβRII, indicated by the absence of a ‘flox’ band (left lane), whereas a ‘flox’ 
band in sorted TEC from Cre- littermates but none for the deleted allele could be detected (Figure 9B, 
right lane). 
To test the deletion efficiency in TGFbRIIlox/lox::Hoxa3-Cre TEC, E13 thymi were cultured for 5 days 
in vitro in the presence of deoxy-guanosine, in order to deplete the lobes from developing thymocytes. 
Analysis of the collapsed thymic rudiment for excision of the floxed sequence gave a similar result as 
observed with the Foxn1-Cre driver (Figure 9C). It has to be taken into consideration, that d-Guo 
depleted fetal lobes contain a significant number of non-epithelial stromal cells (20-30%) that may 
contribute non-recombined genomic DNA.  
 
3.6.5 Hoxa3-Cre-mediated deletion of the TGFβRII allows normal T cell development in 
short-term fetal thymic organ cultures 
 
The fact, that intact TGFβRIIlox/lox::Hoxa3-Cre embryos can be obtained up to 13.5 days post-
conception allowed us to investigate the potential of the developing thymic lobes to support T cell 
development of the first wave of precursors that have reached the organ by that time. As recombination 
in the HSC-derived cells at this point is minimal (see Figure 5B), the effect of missing TGFβ signaling 
in developing T cells were assumed to be minimal. Isolated, untreated thymic lobes were cultured for 
14 days and thereafter assessed for ongoing thymocyte development. As shown in Figure 10, no 
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significant differences in thymocyte subpopulations could be detected. As digestion was used to obtain 
a single-cell suspension, the CD4-CD8 double-negative (DN) stages were excluded from the analysis, 
since this heterogenous population also includes stromal cells, which cannot be safely gated out by 
forward scatter and side scatter characteristics.  
 
3.6.6 Deletion of TGFβRII in the thymic epithelial compartment is associated with an increase 
in thymic cellularity 
 
To test whether Foxn1-specific deletion of the TGFβRII did affect T cell development, cell counts and 
characterization of thymocyte subpopulation by flow cytometry at different time points was performed. 
Whereas thymic cellularity in TGFβRIIlox/lox::Foxn1-Cre mice was comparable to control littermates 
pre- and postnatally up to 4 weeks of age, a consistent and age-dependent increase in thymocyte 
numbers was noted in Cre-positive animals, with an onset shortly after weaning (5 week old mice: 
+10%) reaching an increment of > 40% in 16-month old mice (Figure 11A, B).   
 
A similar effect was seen when transferring lymphocyte-depleted E12.5 or E13 thymic lobes from 
Hoxa3-Cre crossings under the kidney capsule of C57Bl/6 nude mice. In general, these grafts are 
rapidly vascularized and repopulated by T cell precursors. Peripheral T cells were detected as early as 4 
weeks after transplantation (data not shown).  
Despite their usually smaller size, implants derived from TGFβRIIlox/lox::Hoxa3-Cre+/- embryos 
engrafted with similar efficiency (usually 90-100%) as the controls, which contained either a wildtype 
allele of the TGFβRII or lacked the Cre insertion into the Hoxa3 locus. Sections of grafts were 
comparable with respect to cortico-medullary demarcation and TEC subpopulations when subjected to 
H&E staining and immunofluorescence (Figure 12A). Two to three months after transplantation the 
heterotopic thymus along with the spleen were analysed for T cell development and reconstitution of 
the periphery. The cellularity in thymi containing TGFβRII-deficient TEC dramatically exceeded the 
cell number in the control transplants (containing the genotypes TGFbRIIlox/wt::Hoxa3-Cre, 
TGFbRIIlox/wt and TGFbRIIlox/lox) by roughly 2.5 fold (Figure 12B). Similar results were obtained in 3 
independent experiments.  
  
3.6.7 TGFβ-unresponsive TEC support normal T cell development 
 
To assess whether the increase in cellularity in TGFβRIIlox/lox::Foxn1-Cre mice is attributed to a 
specific subpopulation of thymocytes, cell suspensions of thymi at different post-natal stages were 
stained for classical markers characterizing T cell development. 
In general, none of the steps in thymocyte progression was obviously affected, as all populations 
examined were present (Figure 13A). In particular, there was no difference in relative numbers of early 
thymocyte precursors on young and aged mice between the groups (Figure 13B) and absolute amounts 
of the different DN stages (Figure 13C) did not differ.  
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3.6.8 The increase in SP thymocytes found in TGFβRIIlox/lox::Foxn1-Cre mice is due to an 
accumulation of mature SP 
 
A small but significant relative and absolute increase in CD4+ or CD8+ single-positive thymocytes is 
observed in TGFβRIIlox/lox::Foxn1-Cre mice in comparison to wildtype littermates as early as 5 days 
post-partum and increasing with age, summarized in Table 2. In accordance, this is associated with an 
augmentation of CD3high/TCRbhigh thymocytes. SP thymocytes undergo a phase of intrathymic 
maturation within the medulla. These maturational steps include important processes such as negative 
selection, up-regulation of homing receptors for periphery (CD62L) and are characterized by down-
regulation of CD24 and CD69 39,88,96,97,110.  
The increase in SP thymocytes observed in TGFβRIIlox/lox::Foxn1-Cre mice is due to an accretion of 
TCRhigh CD24low cells (Figure 14A) corresponding to mature T cells, ready for egress. Numbers of 
CD44high SP T cells, i.e. activated or memory T cells recirculating from the periphery do not differ 
between the groups (data not shown). Both, CD4 and CD8 SP populations however show an increase in 
frequency and absolute numbers of SP TCRhigh CD62Lhigh thymocytes in TGFβRIIlox/lox::Foxn1-Cre 
mice compared to their wildtype littermates (Figure 14B). The fluorescence intensity of the CD62Lhigh 
thymocyte populations is furthermore increased in Cre positive mice (Figure 14C). The relative shift 
towards a more mature phenotype was also reflected in the characterization according to CD69 and 
TCRb expression. Thymocytes up-regulate CD69 and TCR expression once they receive a positive 
selection signal. Cre-expressing mice showed significantly enlarged populations of TCRhigh CD69positive 
and in particular TCRhigh CD69negative thymocytes (Figure 13D). Analysis of TGFβRIIlox/lox::Hoxa3-Cre 
thymic transplants into nude mice gave a similar picture with a relative increase in CD3high and SP 
thymocytes by roughly a factor 2 (Figure 14E).  
 
Possible mechanisms for accumulation of mature thymocytes include (A) an increased passage time 
due to decreased export frequency, (B) an augmented post-selection expansion with normal passage 
time or (C) alterations in the medullary stromal compartment with a corresponding increase of 
medullary thymocyte numbers without changes in the velocity of their passage through the thymus.   
 
3.6.9 Analysis of proliferation of mature SP 
 
Several studies have denoted the occurence of a post-selection expansion of mature, pre-migrant 
thymocytes. Ernst et al. were the first to identify a SP thymocyte population incorporating BrdU in 
reaggregation cultures of DP with fetal thymic epithelium and and in the normal neonatal thymus. They 
also proposed a microenvironmental factor – potentially TEC-derived cytokines – responsible for this 
marked proliferation 88. It was later shown by Hare 111 et al. that this expansion was in parts IL-7 
dependent. To determine whether the increase in SP was due to the more pronounced proliferation of 
the most mature subset in Foxn1-Cre+ mice, CD24neg/low SP were assayed for DNA content and BrdU-
incorporation. Neither CD4 nor CD8 SP CD24neg/low cells from TGFβRIIlox/lox::Foxn1-Cre mice showed 
more incorporation of BrdU after 2 pulses of BrdU within 6 hrs (Figure 15B, left panel) nor higher 
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DNA content (Figure 15B, right panel), ruling out the possibility of an increased post-seletion 
expansion.  
 
3.6.10 Adult TGFβRIIlox/lox::Foxn1-Cre mice display a reduced thymic export in relation to 
intrathymic SP, although not in absolute numbers 
  
To test whether thymic export is impaired in the absence of TGFβ-signaling in TEC, mice were 
injected intrathymically with FITC, which is passively taken up by the thymocytes. 20-22 hours after 
injection recent thymic emigrants (RTE), i.e. FITC+ CD4+ or CD8+ T cells in spleen and lymph 
nodes, were quantified by flowcytometry and related to intrathymic FITC+ SP cells. As shown in 
Figure 16A, the number of SP exported from TGFβRIIlox/lox::Foxn1-Cre thymi in relation to the total 
number of SP thymocytes is significantly smaller in comparison to their wildtype counterparts. This is 
true both for CD4 as well as CD8 SP. However comparison of the absolute number of exported single 
positive cells shows no significantly different amount of RTE in the periphery (Figure 16B). 
 
3.6.11 Export of mature T cells is delayed in neonatal TGFβRIIlox/lox::Foxn1-Cre mice 
 
Egress of naïve T cells from the newborn thymus provides a different approach to quantify thymic 
egress, as in mice T cells are exported from the thymus only after birth. However, it is crucial to find 
the right time point to measure export: adequately late after birth, to be able to reliably measure 
peripheral T cells, yet early enough not to miss a potential difference as a result of peripheral expansion 
of the T cells in response to homeostatic signals provided by an “empty periphery”.  
Whereas three days post-natal thymic cellularity or intrathymic SP (Figure 17A, left panel) numbers do 
not differ, absolute numbers of splenic CD4+ and CD8+ T cells are – although statistically not 
significantly – reduced in mice with conditional ablation of TGFβ signaling in TEC (Figure 17A, right 
panel), showing one out of three comparable analysis). Whereas differences in absolute numbers of 
peripheral T cells did not reach statistical significance between the groups, pooling the average of the 
frequencies of splenic CD4+ and CD8+ T cells showed a significantly increased frequency in CD8+ T 
cells 3 days after birth using a paired T-test (Figure 17B, right panel). 
 
3.6.12 S1P1 expression by SP thymocytes 
 
Egress of mature SP thymocytes was shown to be regulated by the sphingosine-1-phosphate receptor 1 
(S1P1), which is rapidly up-regulated upon maturation of SP thymocytes 116. FACS-sorted immature 
(CD24high) and mature (CD24low/neg) were analysed by quantitative PCR for S1P1 mRNA levels. As 
expected, there is a dramatic – roughly 9 fold – increase in S1P1 expression in mature vs. immature SP 
of S1P1 in both groups (Figure 18, left panel). However, comparison of S1P1 transcript levels in 
mature SP of Cre+ mice revealed similar levels compared to wildtype littermates (Figure 18, right 
panel).  
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3.6.13 RTE and TCR repertoire in one year old TGFβRIIlox/lox::Foxn1-Cre and TGFβRIIlox/lox 
mice 
 
The immediate consequence of thymic involution is a reduction of thymic output, which can be related 
to TREC+ T cells in the periphery. This appears later as skewing of the TCR repertoire due to unequal 
peripheral expansion of different TCRVβ specificities. TREC copies were quantified in splenocytes 
from TGFβRIIlox/lox::Foxn1-Cre and control mice. In two experiments performed, Cre+ mice showed an 
increase of roughly 30% in TREC copies among their splenocytes. Statistical significance was however 
not reached. One experiment is shown (Figure 19A). In addition Vβ TCR specificities were analysed in 
one-year old mice, which did not show a skewing of the repertoire (Figure 19B) in either group. 
 
3.6.14 Analysis of peripheral T cells in young and middle-aged mice  
 
The peripheral T cell pool is comparable between TGFβRIIlox/lox::Foxn1-Cre and control littermates 
concerning CD3+ CD4+ and CD3+ CD8+ cells in young (10 week old, Figure 20A, left and middle 
panel) and middle-aged (27-30 week old, Figure 20B, left and middle panel). However, whereas the 
number of CD44high, i.e. activated/memory T cells is similar in the young mice (Figure 20A, right 
panel), it is significantly reduced in middle-aged Cre+ mice in comparison to control littermates 
(Figure 20B, right panel). α-CD3/α-CD28-induced proliferation of splenocytes derived from young 
(data not shown) and middle-aged mice (Figure 20C) did not differ between the groups.  
C57Bl/6-nu/nu mice grafted with d-Guo-depleted E12.5 thymi derived from TGFβRIIlox/lox::Hoxa3-Cre 
and control embryos showed comparable number (Figure 20D) and distribution (data not shown) of 
peripheral B and T cells.  
 
These results demonstrate the indirect effects of abolition of TGFβ-signalling in TEC on thymocyte 
development. A second set of experiments was designed to identify alterations of TEC in order to 
explain these findings.    
 
It is well known, that TGFβ negatively regulates the proliferation and induces the differentiation of 
epithelial cells. Direct evidence for its involvement in proliferation and differentiation in thymic 
epithelium is however lacking. 
Among the questions to address was whether the increase in thymic cellularity in 
TGFβRIIlox/lox::Foxn1-Cre was associated with higher TEC numbers or whether an equal number of 
qualitatively superior epithelial cells supported higher numbers of thymocytes. In addition, does TGFβ 
affect the survival and/or sustained proliferation of TEC and could thus the mitigated though not 
abolished thymic involution be explained? How would thymic epithelium non-responsive to TGFβ 
behave and regenerate in the context of acute ‘stressors’? What changes in the epithelial compartment 
– if any were to be found – could explain the increased fraction of mature thymocytes? 
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3.6.15 Thymic epithelium is quantitatively and qualitatively altered in the absence of TGFβRII-
mediated signaling 
 
Thymic epithelial cells in control littermates show a gradual decline with increasing age (Figure 21A). 
In contrast, TEC numbers in 28 week old TGFbRIIlox/lox::Foxn1-Cre mice are unaltered in comparison 
to 8 week old animals. At the age of 64 weeks Cre+ animals also display a reduction of thymic 
epithelial cell numbers. Nevertheless, their numbers are statistically increased in comparison to 
wildtype littermates (Figure 21A). TEC populations can be distinguished according to different MHC 
II expression levels, i.e. MHCIIhigh and MHCIIintermediate. In young mice, i.e. at the age of 8 weeks, no 
difference in absolute cell numbers of MHCIIintermediate TEC was found between the groups, whereas at 
all time points tested the MHCIIhigh population was significantly increased in Cre+ mice (Figure 
21A,B). Further characterization of TEC includes markers to distinguish medullary from cortical 
epithelium. Most of the MHCIIhigh TEC population is derived from the medulla and can as such be 
identified according to reactivity with UEA-1. As expected, the majority of MHCIIhigh TEC bound to 
UEA-1 (Figure 21B) in both mutant and wildtype mice. However, there was a roughly twofold relative 
increase of MHCIIhighUEA-1+ TEC in TGFβRIIlox/lox::Foxn1-Cre mice when compared to control 
littermates (Figure 21B).  
To test, whether the sustained TEC number in 28 week old TGFβRIIlox/lox::Foxn1-Cre mice was 
associated with an increased proliferative capacity of TEC, mice at the age of 4 month were supplied 
with BrdU in their drinking water for a period of two weeks. Thereafter, TEC were assessed for 
incorporation of BrdU into their DNA as an estimate of their proliferative history. Indeed, TGFβRII-
deleted TEC showed a roughly 50% higher frequency of BrdU+ cells (Figure 21C).  
In addition, the phenotype of TEC derived from TGFβRIIlox/lox::Hoxa3-Cre show similar characteristics 
with respect to MHCII expression and UEA-1 reactivity (Figure 21B). 
 
3.6.16 Thymic architecture in aged mice is comparable between TGFβRIIlox/lox::Foxn1-Cre and 
control mice 
 
To assess whether thymic architecture was significantly altered in aged mice, section of thymi derived 
from 54 week old TGFβRIIlox/lox::Foxn1-Cre and control mice were subjected to H&E (Figure 22 i-iv) 
and immunofluorescence staining (Figure 22 v-viii). There is a considerable increase in the area of 
thymic crossection derived from Cre+ mice in comparison to Cre- animals (Figure 22, i&i). Staining 
for the basic stromal markers cytokeratin (CK)-5, CK18 and ERTR7 for the different medullary and 
cortical, as well as mesenchymal cell types do however not show any overt differences (Figure 22, iii-
viii).   
 
3.7 Thymic reconstitution following lethal irradiation and BMT 
 
The link between ionizing radiation, activation of TGFβ and subsequent tissue fibrosis was recognized 
already some time ago. In preclinical tumor models it was demonstrated, that inhibition of TGFβ-
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activity following irradiation has beneficial effects in protecting healthy tissues from fibrosis, whereas 
transformed tissue was rendered more susceptible to irradiation treatment (reviewed in 242). Recently, 
an in vitro study has reported, that apoptotic thymocytes – induced by irradiation or glucocorticoids – 
release active TGFβ1, which exerts immunosuppressive effects 216.  
Therefore, I wished to test (A) whether – and if yes, by what cell type – TGFβ is produced in vivo 
within the thymic confines after lethal irradiation, (B) whether the action of TGFβ on TEC has 
consequences on the speed of thymic immune recovery after irradiation.  
 
3.7.1 Thymic TGFβ1 levels are rapidly up-regulated following lethal irradiation 
 
Quantification of TGFβ1 protein by ELISA in whole thymic lysates derived from lethally irradiated 
mice shows a 20 fold increase within 24 hours compared to non-irradiated controls (Figure 23A). RNA 
message of TGFβ1, measured two and four days after irradiation demonstrates augmented de novo 
transcription of the cytokine (Figure 23B). To identify the cell type involved in the production, 
intracellular staining and consecutive flow cytometric analysis at different time points after irradiation 
was performed. As shown in Figure 23C, the fraction of TEC staining positive for TGFβ increased 
from around 20% in non-irradiated mice to over 90% 40 hours after lethal irradiation, whereas non-
epithelial stromal cells did not show changes in reactivity to this antibody. In non-irradiated animals 
immunohistochemical detection revealed the previously described reticular pattern of active TGFβ1 279, 
mostly localized to subcapsular and cortical areas (Figure 23D i&ii), a feature which was very similar 
to the staining for LAP (Figure 23D iii&iv). 24 hours after lethal irradiation immunoreactivity for 
TGFβ1 localized to specific foci, spread throughout the cortex and to a lesser extent the medulla 
(Figure 23D v&vi)., whereas LAP was barely detectable by these means (Figure 23D vii&viii). In 
addition, detection of phosphorylated Smad2, as a measure of active TGFβ-signaling, by Western 
blotting of whole thymic lysates was much more pronounced in irradiated mice (24 hours post-
irradiation) than in non-irradiated thymi (Figure 23E). Lethal irradiation led to a dramatic reduction of 
TEC numbers 6 days after irradiation, with a roughly 8-fold reduction of the MHCIIhigh and a 5-fold 
reduction of the MHCIIintermediate populations (Figure 23F). 
 
3.7.2 Abrogated TGFβ-signaling in TEC enhances thymic reconstitution after lethal 
irradiation 
 
Our in vitro studies demonstrate an antiproliferative and pro-apoptotic effect of TGFβ on TEC. The 
observed increase in TGFβ levels early after lethal irradiation potentially affects ongoing thymocyte 
development from residual T cell precursors at the DN stage, on the other hand there might be negative 
effects of TGFβ on cell death, proliferation and function of thymic epithelium. To test, whether 
abrogation of TGFβ-signaling in TEC affects reconstitution, TGFbRIIlox/lox::Foxn1-Cre and control 
littermates were lethally irradiated and reconstituted with T-cell-depleted bone marrow (TCD-BM). At 
early time points after irradiation – namely on day 4, 9 and 14 – an equal to or more than 2-fold 
increase in thymic cellularity was observed in mice with TGFβ-unresponsive TEC (Figure 24A). Four 
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weeks after transplantation thymic cellularity was slightly, but not significantly higher in 
TGFβRIIlox/lox::Foxn1-Cre mice compared to controls. Analysis of thymocyte subpopulations on day 14 
post-irradiation showed an equal relative distribution between the two groups in CD4 versus CD8 
FACS blots (Figure 24B). Analysis of DN populations revealed a normal relative distribution (data not 
shown) with a drastic increase in absolute numbers of the different populations (Figure 24C).  
 
3.7.3 The TEC compartment in TGFβRIIlox/lox::Foxn1-Cre mice is partially protected from 
irradiation-induced cell loss 
 
As demonstrated in Figure 23F, irradiation drastically reduces thymic epithelial cellularity. I therefore 
assessed the absolute numbers of thymic epithelium in TGFβRIIlox/lox::Foxn1-Cre mice and controls on 
day 4 and 9 after letal irradiation. Whereas TEC cellularity of non-irradiated mice did not differ 
between the groups (0.42 x106 ± 0.07 x106 vs. 0.41x106 ± 0.07 x106, p>0.05, for TGFβRIIlox/lox::Foxn1-
Cre and TGFβRIIlox/lox respectively) epithelial cell numbers were drastically reduced in both groups, 
although in Cre+ mice to a lesser extend (Figure 25A). The difference was most prominent on day 4, 
and still significant on day 9 after irradiation.  
Two days post-irradiation lysates of whole thymi were assessed for a comparative analysis of transcript 
levels of pro-survival factors. Whereas neither the expression levels of CXCL-12, CCl25 nor IL-7 did 
differ between the groups, c-kit ligand showed a 2.5 fold up-regulation in thymi from 
TGFβRIIlox/lox::Foxn1-Cre mice in comparison to those from control mice (Figure 25B). 
 
3.7.4 Exogenous inhibition of TGFβ prior to irradiation and TCD-BMT enhances early 
thymic reconstitution 
 
Inhibition of TGFβ provided by neutralizing antibodies or TGFβRI kinase inhibitors has proven a safe 
and effective mean in the context of irradiation damage 242. I therefore used purified antibody, reactive 
to and previously shown to neutralize the TGFβ1-3 isoforms. Two times 450µg per mouse 3 and 0.5 
hours prior to lethal irradiation did not affect total thymic cellularity and TEC numbers on day 4 after 
irradiation (Figure 26A). On day 14 however, there was a substantial – yet statistically not significant – 
increase in thymocyte (Figure 26A) and a slight, but statistically significant increase in TEC numbers 
(Figure 26B). 
 
3.7.5 Enhanced thymic reconstitution following lethal irradiation and TCD-BMT requires 
functional Smad4 but is independent of c-myc expression in thymic epithelium 
 
The common Smad4 is required for mediating signals along the canonical pathway induced by TGFβ 
family members 295. C-myc on the other hand is a well-known target gene of the TGFβ signaling 
pathway, whereby TGFβ negatively regulates c-myc expression, thus inhibiting cell cycle progression. 
To assess the consequence of Smad4- or c-myc-deficiency in TEC on the ability of the epithelium to 
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support thymocyte development, Smad4lox/lox::Foxn1-Cre, c-myclox/lox::Foxn1-Cre and control 
littermates underwent lethal irradiation and TCD-BMT.  
Four and fourteen days after irradiation thymi were assessed for thymocyte numbers and development 
and TEC cellularity in relation to their Cre-negative littermates (Figure 27A). Whereas c-myc-deficient 
TEC support an equal percentage of the original thymocyte number as the control TEC, deletion of 
Smad4 in TEC leads to a dramatic reduction of the percentage of the initially sustained thymocyte 
number (Figure 27A). Flow cytometric analysis revealed an increased proportion of thymocytes with a 
low forward scatter and increased side scatter (Figure 27B, left and middle panel). In addition, the 
proportion of DN thymocytes is significantly increased in Smad4lox/lox::Foxn1-Cre mice 14 days after 
irradiation (Figure 27B, right panel), although the distribution of the different DN subpopulations is 
comparable to irradiated control mice at that time point (data not shown).  
 
 
 
3.8 Keratinocyte growth factor (KGF) enhances thymopoiesis synergistically with deficient 
TGFβ-signaling 
 
In several studies KGF was successfully used to reverse thymic involution and enhance thymopoiesis 
following irradiation and stem cell transplantation.  
Six to eight week old female TGFbRIIlox/lox::Foxn1-Cre and TGFbRIIlox/lox mice were injected i.p. with 
recombinant human KGF once daily for three consecutive days. Two weeks after the last injection 
thymocyte cellularity was assessed. As demonstrated in Figure 28, a significant increase of thymocyte 
cellularity relative to the initial thymic cellularity is seen. The composition of thymocyte populations 
did however not differ between the groups (data not shown). 
 
3.9 Ski-deficiency is associated with alterations in thymic size, architecture and thymocyte 
development  
 
Ski-deficient, -heterozygotes and wildtype embryos were dissected for thymic analysis at 14, 16 and 18 
days post-conception (p.c.). E14 thymi in Ski-/- embryos were smaller in size but showed regular shape 
and normal localization in the anterior upper mediastinum close to the heart. Sections of embryonic day 
18 thymi stained with H&E revealed a ‘loose’, uniform texture (Figure 29A ii&iv) in comparison to the 
densely packed thymic lobes with newly forming medullary structures derived from wildtype 
littermates (Figure 28A i&iii). Immunofluorescence analysis confirmed the presence of CD45- and 
CK5+ cells in both groups (Figure 29A v&vi). Yet, whereas wildtype thymi demonstrated a reticular 
pattern of CK5+ cells, localized mostly in the medullary region with some extensions into the cortex, 
Ski-deficient animals demonstrated only few, clumped islets of CK5+ cells. 
To test, whether Ski-deficiency was associated with changes in thymocyte development, E14 thymic 
lobes were cultured for 7 days and thereafter quantified and analysed by flow cytometry for CD4 and 
CD8 expression. Cellularity was reduced slightly in heterozygotes, whereas homozygote deficiency 
 44   
resulted in a reduction of cellularity to roughly 60% to the cell number recovered from wildtype lobes 
(Figure 29B).  
The relative composition of thymocyte subpopulations in Ski-deficient lobes was skewed towards a 
reduction in DP and an increase in SP8 (Figure 29C).  
 
3.9.1 Ski-deficient stroma builds regular thymic structure and exports normal numbers of T 
cells when transferred into nu/nu hosts 
 
E14.5 fetal lobes were depleted of endogenous thymocytes using d-Guo treatment for 5 days in vitro. 
Thereafter the lobes were transplanted under the kidney capsule of C57Bl/6-nu/nu hosts. Peripheral 
blood T cells were collected at 4-weekly intervals, demonstrating similar frequencies of T cells (data 
not shown). Four months after grafting kidneys containing the graft were harvested for histological 
analysis. There was no obvious difference in size between the groups (Figure 30A, left panels) and a 
clear demarcation of cortex and medulla could be seen (Figure 30A, middle panel). Quantification of 
splenic T cells showed equal numbers of TCRβ+ cells in both groups.   
 
3.9.2 Ski-deficient hematopoietic precursors show slight alterations in thymocyte development 
and peripheral T cell pools 
 
To test whether Ski-deficiency influences T cell development, E14.5 fetal liver was harvested from 
Ski-/-, +/- and wildtype embryos and transferred into lethally irradiated C57Bl/6-Ly5.1 mice. All mice 
survived and could be analysed as late as 4-5 months post-transfer. Recipients of Ski-deficient fetal 
liver cells displayed a slight, but significantly reduced thymic cellularity (Figure 30A, left panel). 
Analysis of thymocyte subpopulations revealed a relative and absolute increase of CD8 SP thymocytes, 
whereas the other subpopulations showed no gross differences (Figure 31A, middle and right panel and 
B). Analysis of the different maturational selection stages according to TCR and CD69 expression 
demonstrated a small yet significant skewing towards the more mature, i.e. TCRhigh CD69high and 
TCRhigh CD69low stages (data not shown).  
In addition, less splenocytes were recovered from recipients of Ski-deficient fetal liver cells in 
comparison to recipients of heterozygote or wildtype fetal liver cells. This decrease was due to a 
reduction of CD19+ cells (data not shown). Whereas the CD4+ T cells showed a comparable frequency 
between the groups, Ski-deficient CD8a+ T cells were highly overrepresented in relative (Figure 31C, 
right panel) and absolute (data not shown) terms.  
Analysis of protein levels in wildtype thymocyte subpopulations revealed a drastic increase of Ski 
expression in DP thymocytes, whereas DN and SP contain relatively low levels of the protein (Figure 
31D, left panel). In concurrence with this finding is the inverse pattern for phosphorylated Smad-2 
levels in these subpopulations with barely detectable levels in DP but relatively high levels in DN and 
especially SP thymocytes (Figure 31D, right panel). Peripheral lymphocytes (assumed from total 
splenic lysates) express relatively low levels of Ski protein.  
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4 Discussion 
 
There is virtually an endless wealth of literature the many facets of TGFβ, including expression 
patterns, production and its regulation, distribution and activation in tissues, signaling components and 
regulators thereof, and finally its effects, which on the one hand seem to induce stereotypical cellular 
responses via ‘canonical’ pathways, but on the other hand – after more than two decades of intense 
research – never ceased to stimulate and surprise the research community.  
Whereas an increasing number of reports has elucidated TGFβ-mediated effects on the development 
and function of immune cells, its in vivo role for TEC development and function remain enigmatic.  
 
4.1 Expression of TGFβ during embryogenesis and in the adult mouse 
 
Early studies have resolved the spatial and temporal resolution of TGFβ expression in the mouse 
embryo 227,228,296, demonstrating strong expression in the developing thymus as early as E12.5 in the 
mouse embryo 228,297. Previous lab members have extended these findings by carefully analyzing the 3rd 
pharyngeal pouch containing the precursors that will give rise to thymic epithelium around E10.5, i.e. 
prior to immigration of T cell precursors (Y. Mathieu, K.Y. Na). Table 1 summarizes qualitative data 
(i.e. obtained by end-point PCR) of TGFβ isoform transcripts and their respective ligands at different 
time points during embryogenesis and in the adult. TGFβRI and II show a wide tissue distribution and 
are believed to be constitutively transcribed 295. This is reflected by the fact that their signal was 
detected in all samples tested in primary TEC and TEC lines (Table 1). TGFβ-induced transcription is 
tightly regulated by association of nuclear factors with the transcriptionally active complex298. Ski and 
Sno negatively regulate TGFβ-signaling and transcription. Ski, but not Sno was detected in the 3rd 
pharyngeal endoderm demonstrating the presence of at least one negative regulatory element in 
developing TEC. These findings suggest a role for TGFβ during early thymic development, in 
particular with respect to TEC development, proliferation and differentiation. This issue has not been 
addressed so far. In the ageing organism on the other hand, increased TGFβ expression in human 
thymic tissue is suspected to negatively influence involution and possibly enhances tissue fibrosis 174. 
We therefore tested, whether TGFβ expression was altered in aged versus young mice. In fact, there 
was only a slight and transient increase in TGFβ1 expression with age, whereas TGFβ2 expression 
showed a steady increase. Nevertheless, as these findings might not reflect the actual protein levels of 
TGFβ, due to extensive post-transcriptional regulation, we performed analysis for total TGFβ protein 
by Western blot, demonstrating indeed a steady increase of TGFβ on a protein level. However, 
interpretation of these findings in terms of biological relevance has to be made cautiously, as the actual 
TGFβ-activity does not necessarily correspond with the presence of the protein, due to inactivating 
complex formation with other proteins and extracellular matrix 299. Nevertheless, I was furthermore 
interested in what specific cell type(s) expresses TGFβ isoforms in the thymus. To this end, I 
established an intracellular cytokine staining for flow cytometry. Interestingly, analysis of young mice 
revealed a large fraction of DN and a smaller fraction of both TEC and non-TEC stromal cells 
demonstrating immunoreactivity, whereas the largest fraction of other thymocyte subpopulations did 
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not react with the antibody. This is in line with earlier findings of TGFβ-production by thymocytes and 
cultured thymic epithelium 216,228,281,300,301. It remains to be shown however, if there is a change in the 
expression pattern in aged mice.  
 
4.2 TEC respond to TGFβ in vitro 
 
Due to scarcity of epithelial cells within the thymic compartment, the rapid loss of TEC-specific 
functions in culture as well as their inclination for apoptosis when removed from their three-
dimensional network hampers the study of primary adult TEC. Yet, I tried to get an idea about the 
effects of TGFβ on TEC using two different systems. On the one hand, established TEC lines (derived 
from neonatal thymi 302) on the other hand thymocyte-depleted fetal lobes (containing 60-70% 
epithelial cells) were exposed to TGFβ. As demonstrated in Figure 2Ai and ii, TEC lines (results 
shown for TEC1.2) rapidly activate the canonical TGFβ-signaling pathway as demonstrated by 
phosphorylated Smad2, which translocates to the nucleus. The cellular effects observed are inhibition 
of proliferation and for some TEC lines activation of apopototic pathways. The most reproducible 
transcriptional changes imposed by TGFβ on TEC is the down-regulation of c-myc transcription. In 
fact, whereas c-myc was consistently repressed in all TEC lines tested within 24-48 hours, transcript 
levels for cell cycle regulators such as the CDKs p16, p21 and p27 showed a great variability 
depending on the time point after stimulation used for analysis. In addition, the serum concentration 
within the culture medium correlated with the anti-proliferative and partially pro-apoptotic effects of 
TGFβ, indicating an antagonizing factor in the animal serum. Therefore TEC lines were routinely 
starved overnight in medium without serum prior to stimulation to achieve the most prominent and 
consistent effect. A slightly more physiological situation is found in d-Guo depleted fetal thymic lobes, 
whereby the three-dimensional meshwork of TEC is retained despite the absence of thymocytes. This 
‘empty stromal bag’ expresses cytokines and surface molecules required for thymocyte development 
303. Addition of TGFβ to the cultures induced drastic numeric reduction of the epithelial– in particular 
the MHCIIhigh – fraction within 36 hours, at least partially induced by reduction of proliferation. TGFβ 
was previously reported to induce down-regulation of MHCII via repression of CIITA 304,305. In our 
system it is however unlikely, that TGFβ exerts the reduction of MHCIIhigh cells via targeting of 
CIITA, as the absolute number of MHCIIlow cells remained constant during this relatively short culture 
period. Interstingly, the non-epithelial fraction was not significantly reduced, indicating that TGFβ 
preferentially affects thymic epithelium. On the other hand, an indirect effect of TGFβ via non-
epithelial stromal cells cannot be excluded (e.g. down-regulation of growth factors provided by 
mesenchymal cells). This in vitro model provides a suitable tool to examine the effects of TGFβ on 
ligand-induced TEC differentiation and proliferation, as well as on their production of cytokines or 
chemokines.  
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4.3 Elucidating the role of TGFβ-signaling in TEC in vivo 
 
The contribution of TGFβ to TEC development and function under steady-state conditions can only be 
studied using conditional ablation of a vital signaling component with a high specificity for TGFβ. 
TGFβRII is the most suitable target to date, as it initiates the signaling cascade by complexing the 
ligand with the TGFβRI. As TGFβRIInull mice die around E10.5, i.e. prior to the formation of the 
thymus, TEC-specific inactivation of the TGFβRII is required. Conditional ablation of this receptor 
was successfully demonstrated 294. Yet, prior to crossing TGFβRIIlox/lox mice to Cre-expressing mice, 
the different Cre-drivers, i.e. Foxn1-Cre, Hoxa3-Cre and Lefty-Cre, had to be tested for the specificity, 
timing and reliability of Cre-expression.  
 
4.4 Characterisation of Cre-mediated deletion using different Cre-drivers 
 
To test the timing and specificity of the Cre recombinase under different promoters, I analysed 
crossings to the GFP- and LacZ-reporter strains, which express either GFP or β-galactosidase in the 
cell type where Cre recombinase has successfully excised the floxed sequence. The transcription factor 
Foxn1 is specifically expressed in thymic epithelium early during development and in keratinocytes. 
Cre expression under the transcriptional control of Foxn1 should therefore target recombination 
specifically to these cell types. This was demonstrated for the E12.5 thymus using the LacZ-reporter 
strain (S. Zyklus, in press). However, I wished to know the recombination efficiency at later time 
points and on a single-cell level, which is best achieved by FACS analysis. Therefore I analyzed thymi 
derived from GFP-reporter::Foxn1-Cre+ and Cre- E15 embryos and adult mice. E15 TEC showed a 
high recombination efficiency of roughly 85%. The results derived from embryonic TEC are in line 
with the observations by Itoi et al.8, demonstrating a roughly 80% expression of Foxn1 in cytokeratin-
positive TEC at E13. Foxn1 expression was shown to be non-redundant for maturation of TEC in a 
cell-autonomous manner 5, meaning that all MHCII-expressing TEC should have - at one point during 
their maturation – expressed Foxn1. However, by flowcytometric analysis only about 60-70% of 
MHCIIhigh/intermediate TEC derived from adult GFP-reporter::Foxn1-Cre+ mice gave a GFP signal. 
Different scenarios could explain this finding:  
(A) technical difficulties including loss of GFP during the isolation procedure or inefficient 
reporter activity are unlikely, as GFP-reporter::Hoxa3-Cre+ would demonstrate a similar 
finding which is not the case (see below). 
(B) Inefficient Cre-expression and/or –activity are again unlikely as detection of deletion in the 
TGFβRIIlox/lox::Foxn1-Cre crossing showed a high recombination efficiency of the floxed 
allele, although locus accessibility might play a role.  
(C) Delayed expression of the reporter construct or in contrast silencing thereof might account for 
this finding and cannot be completely ruled out. 
I therefore tried another approach to identify Cre-expressing cells by flow cytometry, namely direct 
detection of the protein using anti-Cre antibody. As positive control served TEC derived from Aire-Cre 
mice, which demonstrate Cre-immunoreactivity in a subpopulation of MHCIIhigh TEC (Figure 4B, right 
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panel). TEC obtained from adult Foxn1-Cre-expressing mice however did show – if any – only a slight 
immunoreactivity, which suggests very low levels of protein expressed. Retrospectively, this is 
however not surprising, as only a small fraction of TEC express Foxn1 at this stage8 and its promoter 
activity might be very weak. In addition, kinetics of Cre-protein turnover might be high, leading to low 
protein levels.  
Characterization of Hoxa3-Cre-expressing mice was somewhat less puzzling. Surprisingly however 
was the finding, that at E14 and also at E19 of the thymic cell populations only epithelial cells showed 
a high level of recombination, whereas mesenchymal cells and thymocytes recombined only in a small 
fraction of cells. This unexpectedly high specificity of Cre-expression for TEC together with the fact 
that a large proportion of cells in the third pouch area has recombined by 10.25 (Figure 5A, middle and 
lower panel) provides a useful tool to conditionally ablate genes in TEC-precursors during the 
inductive phase of thymic development. Its use is only limited by the fact that Hoxa3 shows a wide 
tissue distribution outside the 3rd pouch area during midgestation (Figure 5A, upper panel). This 
particular problem was encountered in the context of homozygosity for either the Smad4lox or the 
TGFβRIIlox allele and Hoxa3-Cre expression, which both resulted in early fetal lethality (Figure 5C and 
7B, respectively).  
 
Mesenchymal-epithelial interactions through secreted molecules or membrane-bound receptors play 
crucial roles during organ induction, which was demonstrated for early thymic organogenesis 306. 
Conditional ablation of genes in either compartment will therefore reveal their respective contribution 
to organ development. The lefty-Cre mouse was generated in the lab of Anne Moon, Salt Lake City 
and proposed to show mesenchymal specificity (personal communication). However, analysis of Cre-
expression in thymic cell populations using the described reporter strains revealed recombination 
mostly in thymocytes, but only in a small fraction of mesenchymal cells (Figure 6). This mouse was 
therefore not used for further studies.  
 
4.5 Lack of TGFβRII in Foxn1 expressing cells does not lead to skin or lactation defects 
  
Foxn1 is expressed in the matrix, cortex and outer root sheet of the hair and in suprabasal layers of the 
epidermis 13. Consecutively, Cre-mediated recombination was detected in the skin of LacZ-
reporter::Foxn1-Cre mice. TGFβRIIlox/lox::Foxn1-Cre mice did however not show an obvious skin 
phenotype with regards to stability, keratinization problems or hair or nail loss. Detailed analysis was 
not performed and TGFβRIIlox/lox::Foxn1-Cre  mice might be a valuable tool for analyzing the 
contribution of TGFβ-signals to skin homeostasis, wound healing and (induced) carcinogenesis. 
 
Since the first description of the nude mouse it was appreciated that Foxn1-deficient mice (i.e. nude 
mice) were unable to maintain a litter, despite normal fertility. This was attributed to their reduced 
capacity to lactate. The expression pattern of this transcription factor or its exact contribution to initiate 
or maintain a functional mammary gland has not been described. The Foxn1-Cre mouse provides a 
valuable tool to elucidate the expression pattern of Foxn1 in the murine mammary gland and to 
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conditionally ablate or activate genes to study their role in physiological (pregnancy, lactation, 
regression) as well as pathological conditions (e.g. breast cancer). Preliminary data obtained in 
Rosa26lacZ::Foxn1-Cre female mice indicate, that Foxn1 is expressed during differentiation of the 
mammary epithelium in pregnancy, whereas no β-galactosidase staining is detected in the mammary 
gland during puberty or under adult steady-state conditions. TGFβ plays a multifaceted role during 
branching, specification and carcinogenesis of mammary epithelium 307. However, 
TGFβRIIlox/lox::Foxn1-Cre female mice were routinely used for breeding and they sustained normal 
litter sizes. This indicates no immediate deleterious influence of perturbed TGFβ signaling on the 
lactating mammary gland. However, detailed histological analysis of mammary glands was not 
performed and further studies of the absence of TGFβ signaling on involution of the mammary gland 
after involution or upon transforming agents should be stimulated.  
 
4.6 Cre-mediated deletion of TGFβRIIlox/lox in thymic epithelium at different stages is 
efficient but results only in a minor thymic phenotype in young mice 
 
Considering the expression pattern of TGFβ and its receptors in the developing thymus at all stages 
tested, it came as a surprise, that thymic development as well as TEC maturation proceeded unhindered 
when TGFβRII was deleted from thymic epithelium, and resulted in a microenvironment that 
supported normal T cell development. Insufficient deletion efficiency could be ruled out as the 
underlying cause in embryonic and adult TEC (Figure 7). Cre-activation in TEC beyond a stage with 
indispensable requirement for TGFβ-signaling could also be excluded, driving Cre under control of a 
promoter active prior to TEC commitment (ref. 14 and Figure 5A). Whereas other studies tried to 
address this issue studying mice deficient for TGFβ isoforms 282 – thus not ruling out (partial) 
redundancy between the isoforms as well as trans-placental transfer 230 – this work is the first to 
exclude a non-redundant role of TGFβ-signaling in TEC via TGFβRII for induction and migration of 
the thymic anlage as well as for attraction of thymocyte precursors and their further maturation 
(Figures 8, 10, 11 and 13).  
An important and complex role has been assigned to TGF-β signaling for regulating the expansion, 
activation and effector functions of mature T cells in peripheral lymphoid organs and target tissues 
during an adaptive immune response 224, whereas intrathymic TGFβ-requirement for normal T cell 
development is debated 287-289.   
Which cell type(s) therefore rely on the presence of TGFβ during thymic organogenesis? The 
formation of the pharyngeal apparatus involves coordinated actions between neural crest cells and cells 
of ectodermal, endodermal and mesodermal origin 308. Moreover, TGF-β signaling may be required in 
the 3rd pharyngeal arch for non-epithelial cells that influence TEC development and function. Indeed, 
neural crest stem cells are responsive to TGF-β family members 54-56. Ablation of TGFβRII-mediated 
signaling in neural crest cells alters their post-migratory differentiation, consequently reducing the peri-
thymic condensation of mesenchyme and diminishing the detection of neural crest-derived cells in the 
established thymic cortex 65. Interestingly, these morphological changes correlate with a significant 
decrease in thymus size and other defects and are consistent with a proposed role of neural crest cells in 
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thymus organogenesis 65, 46. Thus, the requirement for TGFβ during thymus organogenesis is 
independent of direct signaling to TECs but appears to be indirect via the involvement of neural crest 
cells and mesenchymal-epithelial cross-talk during thymus organogenesis 309. 
 
4.7 TGFβ-signaling in TEC contributes to thymic involution 
 
The molecular mechanisms operational in the process of senescence-related thymic involution are not 
precisely known despite their relevance for the loss of immunological competence in the aged. 
Indications that TGF-β signaling may be involved in this process have been largely correlative, such as 
increased TGF-β steady state mRNA levels in the ageing human thymus 174, without evidence for a 
causative role. More recently, haploinsufficiency for TGF-β2 was shown to be associated with a 
decreased rate of thymic involution. Although this observation has been attributed to the action of 
TGFβ on early thymopoiesis, bone marrow transplantation experiments suggest that the decrease in 
thymic involution was at least in part the consequence of altered functions of the thymic stroma 154. 
The data presented in this study are clearly in support of the view that TGFβ signaling in TECs is 
directly associated with the phenomenon of thymic involution. Although the absence of TGFβRII in 
TEC did not prevent involution, its onset was delayed and the progression mitigated (Figure 11A&B). 
Delayed involution was furthermore associated with reduced frequency of CD44high – i.e. 
activated/memory T cells – and slightly increased numbers of TREC+ cells in the periphery of old 
TGFβRIIlox/lox::Foxn1-Cre mice (Figure 20A). Differences in TCRVβ usage in one-year old mice were 
however not seen between the groups, indicative that thymi in either group still showed significant 
output (Figure 20B). It remains to be tested whether such differences would occur in older animals (≥ 2 
years old). These findings in TGFβRIIlox/lox::Foxn1-Cre mice are supported by the dramatically 
increased cellularity observed in grafted thymic derived from TGFβRIIlox/lox::Hoxa3-Cre embryos 
(Figure 12B).  
Interestingly, the frequency and absolute numbers of ETP as well as developmentally more advanced 
DN thymocytes in aged experimental animals were comparable to controls (Figure 13B), ruling out 
enhanced attraction of precursors by TGFβRIIlox/lox::Foxn1-Cre mice as the underlying cause for 
mitigated involution.  
Consistent with the role of TGFβ in negatively regulating cell cycle 300 TECs deficient in TGF-
β signaling retain a higher proliferative capacity (Figure 21C) which correlates with an increased 
representation of these cells in TGFβRIIlox/lox::Foxn1-Cre mice (Figure 21A). Yet, the overall structure 
of the thymic microenvironment was unaffected despite the lack of TGF-β signaling in TEC (Figure 
22). Therefore, the observation of a mitigated thymic involution in the mutant mice suggests that the 
enlarged stromal compartment is able to host an increased number of thymocytes. Nevertheless, the 
thymocyte-to-TEC ratio decreased with age in both mouse strains (data not shown) arguing for the fact 
that TGFβ signaling in TEC is not uniquely responsible for the phenomenon of thymic involution. 
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4.8 Subtle changes in thymocyte development induced by the absence of functional TGFβ 
signaling in TEC 
 
The corollary of the loss of TGFβ signaling in TEC on thymocyte development is subtle but causes a 
consistent and significant accumulation of mature single positive thymocytes. This increase is unlikely 
to be caused by T cells re-circulating from the periphery to the thymus but is rather reflective of an 
accumulation of mature post-selection thymocytes, because these cells are low in their expression of 
CD24, CD69 and CD44 but display high surface concentrations of CD62L 139. The sphingosine-1-
phosphate receptor 1 (S1P1) is rapidly up-regulated by mature thymocytes and facilitates egress. 
However, no differences are detected between CD24low/neg SP thymocytes between the groups (Figure 
19).  
A higher proliferative rate of mature thymocytes which would have accounted for their increased 
frequency could also be excluded, suggesting a local retention of these mature cells within the thymic 
microenvironment. In support of this conclusion are three additional observations: the increased 
detection of these phenotypically mature thymocytes in TGFβRIIlox/lox::Foxn1-Cre mice as young as 5 
days of life (Table 2), the lower frequency and absolute numbers of peripheral T cells 3 days post-
natally (Figure 18) and the significantly smaller fraction of mature thymocytes that are exported to the 
periphery in young adult TGFβRIIlox/lox::Foxn1-Cre mice. The observed alterations in the composition 
and size of the thymic microenvironment might provide an explanation for these changes in 
thymopoiesis in TGFβRIIlox/lox::Foxn1-Cre mice because an enlarged (and possibly functionally 
altered) stromal scaffold is likely to accommodate more and possibly different thymocytes. In fact, the 
relative and absolute expansion of UEA-1+MHCIIhigh TEC – i.e. a medullary subpopulation – in 
TGFβRIIlox/lox::Foxn1-Cre (and TGFβRIIlox/lox::Hoxa3-Cre) mice in comparison to control littermates is 
associated with this increase in mature thymocytes. As thymocytes at different maturational stages are 
located to specific ‘zones’ within the thymus 310, one could thus hypothesize, that the enlarged 
medullary stromal compartment will be filled up with thymocytes restricted to this area, leading to an 
increased pool of medullary i.e. SP thymocytes, without any functional relevance. In line with this 
hypothesis is the finding, that the fraction of mature thymocytes in TGFβRIIlox/lox::Foxn1-Cre does not 
show a steady increase over time, but levels off and actually reaches in old animals levels comparable 
to control mice, concurrent with a reduction of medullary epithelium in TGFβRIIlox/lox::Foxn1-Cre 
mice.  
 
4.9 Enhanced thymic reconstitution in TGFβRIIlox/lox::Foxn1-Cre mice following γ-
irradiation and BMT  
 
Irradiation has a negative impact on thymic cellularity, concerning mostly thymocytes but also 
epithelial cells in a dose-dependent fashion 214,215. Following irradiation, thymocytes release high 
concentrations of TGFβ resulting in an immunosuppressive milieu in vitro 216. This mechanism might 
well be operational in vivo, and not only affect thymocyte differentiation directly but also influence 
stromal cell types. Indeed, exposure of thymic epithelia to TGFβ  modulates the production of 
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cytokines important for T cell development 186. We demonstrate here, that TGFβ1 transcript and 
protein levels are dramatically increased following irradiation in normal thymi. Whereas thymocytes 
might release a large portion of prestored protein, thymic stromal cells in general and TEC in particular 
are responsible for the de novo production (Figure 23C) of active protein, as indicated by lack of LAP-
staining. The presence of active TGFβ is furthermore supported by increased levels of phosphorylated 
Smad2 in irradiated thymi. As previously demonstrated 214,215, thymic epithelial cell numbers are 
drastically reduced within 6 days after irradiation (Figure 23F). In particular, damage to the MHCIIhigh 
population is most extensive. This negative impact of irradiation on TEC and total thymic cellularity 
was dampened in the absence of TGFβ-signaling in TEC (Figure 24 and 25), with a more rapid 
recovery following the insult in TGFβRIIlox/lox::Foxn1-Cre mice.  Whereas decreased cell loss 
following irradiation might account for the rapid recovery in TGFβRIIlox/lox::Foxn1-Cre mice, 
intrathymically produced TGFβ might indirectly affect on thymocyte development via inhibition of  the 
production of cyto- and chemokines. Interestingly, 48 hours following irradiation there was a 2.5 fold 
increase in SCF expression in thymi derived from TGFβRIIlox/lox::Foxn1-Cre mice (Figure 25B), 
whereas the cellular composition of thymi did not differ between the groups. One might hypothesize, 
that increased levels of SCF at this early time point might enhance the proliferation (and survival) of 
residual and DN1 and DN2, which is in line with preliminary data showing enhanced proliferation of 
these cells early after irradiation in TGFβRIIlox/lox::Foxn1-Cre mice. In addition, TEC apoptosis and 
proliferation following irradiation in the absence of TGFβ-signaling remains to be demonstrated. TGFβ 
is amenable to exogenous inhibition using specific antibodies or small molecule inhibitors 311, a 
principle which was tested with some limited success - with regards to thymocyte cellularity and TEC 
numbers - in the context of thymic reconstitution following lethal irradiation (Figure 26). Changes in 
timing and dosing or the use of small molecule inhibitors might prove more effective. A direct effect 
on thymocyte development by these compounds cannot be excluded. One experimental approach to 
exclude a direct effect of TGFβ on thymocyte development in this system lies in the transfer of 
TGFβRII-deficient bone marrow into lethally irradiated host with consecutive analysis of the speed of 
immune reconstitution.  
Smad4 is an essential molecule involved in canonical TGFβ-signaling, yet lacks specificity for TGFβ-
mediated signals, as other TGFβ-family members also rely on Smad4. Interestingly, Smad4-deficiency 
in TEC led to a protracted reconstitution following irradiation in conjunction with drastic increases in 
the fraction of FSClowSSChigh – indicative of apoptosis – and DN thymocytes in thymi from irradiated 
Smad4lox/lox::Foxn1-Cre mice (Figure 27). These findings might imply that (A) signals of other TGFβ-
family members in TEC are essential or (B) an imbalance between canonical and non-canonical 
pathways in TEC is deleterious for T cell development under these circumstances. This issue is 
currently addressed using conditional inactivation as well as conditional activation of the BMP receptor 
Alk2 in TEC for reconstitution experiments. C-myc down-regulation is recognized as a critical event in 
the cell cycle arrest response of epithelial cells to TGFβ-stimulation, and therefore might be a potential 
target molecule of TGFβ in TEC affecting their proliferation and consequently T cell reconstitution 
following γ-irradiation. Yet surprisingly, TEC-specific deletion of c-myc did not show a negative effect 
on T cell reconstitution. The fact that conditional ablation of c-myc in TEC results in an increased 
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thymocyte/TEC ratio, which is even more pronounced after irradiation and reconstitution (data not 
shown) indicate qualitatively superior epithelium in the absence of c-myc. Although the underlying 
molecular mechanisms remain to be demonstrated, this adds a new facet to TEC biology.  
Keratinocyte growth factor (KGF) stimulates proliferation and function of thymic epithelium and was 
shown to enhance thymopoiesis via protection of TEC in the context of irradiation/BMT 312313. On the 
other hand, TGFβ and KGF demonstrate antagonistic activities 314,315. In fact, a synergistic effect was 
seen between the absence of TGFβ-signaling in TEC and KGF treatment. Its effectiveness in the 
context of post-irradiation reconstitution is part of ongoing studies.  
 
Although there is a wealth of information concerning the effect of TGF-β signaling on T cell 
development, only relatively little is known regarding the in vivo role of TGF-β for TEC development 
and function. The present study presents insight into the contributions of TGF-β signaling under both 
steady state conditions and after lethal irradiation. Here, we demonstrate that the loss of TGF-β 
signaling in TECs is not essential for thymus organogenesis but affects (i) total thymocyte cellularity as 
a function of age, (ii)  the pool of mature thymocytes, (iii) the phenotype, proliferation and cellular 
composition of the thymic epithelial compartment, and (iv) the capacity of TEC to support early 
reconstitution of thymopoiesis following irradiation.  
 
4.10 Negative regulation of TGFβ-signaling by Ski and its involvement in TEC and T cell 
biology 
 
As a complementary approach to conditional deletion of TGFβ-signaling in TEC I wished to assess 
whether uninhibited TGFβ-signaling in the same cell type would demonstrate phenotypic and 
functional alterations. Ski is considered a potent transcriptional repressor of TGFβ-signaling. Ski-
deficient animals die prior to or immediately after birth due to craniofacial abnormalities and failure of 
neuropore closure316. Thymic analysis has to be undertaken similarly to the one in 
TGFβRIIlox/lox::Hoxa3-Cre. Thymi of embryos beyond E13 were smaller in size but showed a regular 
localization in situ. Although cultured Ski-/- lobes demonstrated regular thymocyte development, 
thymocyte cellularity was drastically reduced in comparison to wildtype lobes. Analysis of TEC in E18 
lobes revealed aberrant phenotypical changes with loss of the reticular pattern of cytokeratin staining 
and forming of small epithelial islets in Ski-/- thymi. However, when Ski-deficient, thymocyte depleted 
E14 thymic lobes were transplanted into nude recipients an inconspicuous architecture and similar T 
cell numbers were seen 8-10 weeks after transplantation in comparison to transplanted wildtype lobes. 
The discrepancy between the embryonic findings and the grafted thymi might be explained by 
defective support of TEC by mesenchymal cells 316. Of interest was the finding that transplantation of 
Ski-deficient fetal liver precursors into irradiated hosts led to a small but significant reduction of 
thymic cellularity in comparison to recipients of wildtype fetal liver. This was attributable to a 
significant decrease of Ski-/- DP. In contrast, there was a significant increase of CD8 SP in recipients 
of Ski-/- fetal liver. This difference was ‘exported’ to the peripheral lymphoid organs of these mice, 
with a significant relative increase in CD8+ T cells. These findings prompted me to analyse Ski protein 
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levels in the different thymocyte populations and peripheral T cells of wildtype mice. Ski protein is 
very abundant in the thymus, mostly attributable to DP thymocytes, whereas DN and SP show low 
levels of the protein. This correlated directly with Smad-2 posphorylation. Indeed, besides its role in 
negatively regulating Smad2-dependent transcription recent reports suggest a direct role for Ski in the 
de-phosphorylation of Smad2 317,318. Recent reports using conditional inactivation of TGFβRII in 
developing T cells have shown a reverse pattern of thymocyte frequencies, with a decrease of mature 
CD8SP thymocytes 289.  
Collectively, these findings demonstrate a minor – if any – role for Ski in TEC development and 
function. However, the tight regulation of Ski protein expression during T cell development with high 
expression levels at the DP stage imply a specific role for this molecule, possibly during CD4/CD8 
lineage decision or positive selection. The Ski-deficient mouse provides an exciting new model in 
order to study the potential regulatory role of TGFβ in thymocyte development. 
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5 Conclusions 
 
- Cre recombinase expression under the control of either the Hoxa3 or the Foxn1 promoter 
provide reliable and relatively specific tools to conditionally inactivate genes of interest in 
thymic epithelial cells at different stages of development in order to study inductive  events (in 
the case of Hoxa3-Cre mice) and steady-state conditions (in the case of Foxn1-Cre mice). 
- TGFβRII expression in thymic epithelial cells is not required for thymic epithelial cell 
development, as it does not affect maturation into the different TEC subpopulations. 
Nevertheless, they demonstrate an enlarged pool of medullary epithelial cells. Although 
permitting essentially normal T cell development, this results in  an increase of medullary T 
cell numbers and a decreased export of mature T cells into the periphery, relative to the 
number of intrathymic T cells.  
- TGFβ-signaling in thymic epithelium plays a role in promoting thymic involution with 
respect to onset and progression. Inactivation of TGFβ signaling in TEC is associated in 
delayed loss of TEC over time and positively influences the proliferative capacity of thymic 
epithelium. 
- TGFβ is prestored in and released by thymocytes following γ-irradiation. As a consequence, 
the cytokine has detrimental effects on thymic reconstitution early after γ-irradiation. 
Abolishion of TGFβ-signaling protects TEC from radiation-induced cell death. In addition, the 
proliferative capacity of TEC in response to irradiation is enhanced in the absence of TGFβ-
singaling. TGFβ also acts as a negative regulator of ‘thymostimulatory’ cytokines such as 
SCF, which are required for proliferation and survival of thymocyte precursors. Preliminary 
data furthermore suggest, that keratinocyte growth factor – currently explored as a TEC-
protective factor in the context of hematopoetic stem cell transplantation – acts synergistically 
with inhibition of TGFβ-singnaling. Recent advances in the development of clinically useful 
small molecule inhibitors for TGFβ signaling provide an impetus for further studies in this 
field.  
- TEC development is marginally affected by TGFβ . This is further underscored by the finding, 
that the absence of Ski – a potent negative regulator of TGFβ-induced transcription – in 
thymic epithelium does not influence TEC development. However, although recent work 
indicates that the absence of TGFβ-signaling in thymocytes is redundant, our studies using 
Ski-deficient hematopoietic precursors suggest a role for TGFβ signaling in the lineage 
decision of CD4+CD8+ double-positive thymocytes and peripheral homeostasis of CD8+ T 
cells.  
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7 Materials and Methods 
 
 
Mice 
LacZ-reporter mice:  B6;129-Gt(Rosa)26Sor<tm1Sho> were purchased from Jackson laboratories, 
stock number 003504 
GFP-reporter mice: B6;129-Tg(CAG-Bgeo/GFP)21Lbe/J were purchased from Jackson laboratories, 
Stock Number 003920 
Foxn1-Cre mice: Foxn1-Cre mice were produced as PAC transgenic animals (S. Zyklus, 
G.A.Holländer, in revision). Briefly, the cds for iCre (for eukaryotes codon usage optimized version of 
the bacteriophage p1 cre recombinase) was inserted into PAC clone RPCI21-436p24. Successfully 
modified BACs were purified and injected into C57Bl/6xBDF1 pronuclei by the transgenic mouse core 
facility (TCMF) of the Biozentrum at the University of Basel. Offspring was screened for transgene 
integration by PCR.  
TGFβRIIlox/lox mice: TGFβRII conditional knockout mice were a kind gift of Dr. J. Roes at the 
Windeyer Institute of Medical Sciences, University College, London. Generation of the mice is 
described in 294.  
Rag2-/- mice were a kind gift of Prof. A. Rolink, Zentrum für Biomedizin, Universität Basel. 
C57Bl/6 mice were purchased from RCC Ltd, Füllinsdorf 
C57Bl/6-Ly5.1 mice: B6.SJL-PtprcaPep3b/BoyJ mice were obtained from Jackson Laboratories (Bar 
Harbor, ME, USA) 
B6.Foxn1nu/nu mice were obtained from Jackson Laboratories (Bar Harbor, ME, USA) 
 
Thymic epithelial cell lines 
TEC1.2, TEC1.4, TEC2.3, TECC6, TECC9 were a kind gift from Dr. M. Kasai (Tokyo, Japan). They 
were cultured in IMDM-2% and detached if appropriate using Trypsin 0.25% (Gibco). 
 
Buffers 
Medium for cell cultures 
 IMDM (Gibco, Lubio, Lucerne) 
  for TEC cultures: add 2% fetal calf serum 
for T cell assays: add 10% fetal calf serum, 2-mercaptoethanol (Gibco, Lubio, 
Lucerne) 
 
Antibiotics 
in all cultures Kanamycin sulphate 100x (Gibco, Lubio, Lucerne), diluted in culture medium to 1x was 
used 
 
FACS buffer (used for staining of cells for flow cytometry) 
Phosphate buffered saline, pH7.4, containing 2% fetal calf serum (Perbio, Lausanne) 
for stromal cell stainings 5mM EDTA (final concentration) was added (Invitrogen, Lubio, 
Lucerne) 
 
 
Red blood cell lysis buffer 
- 8.84g NH4Cl 
- 0.037g EDTA 
- 1g NaHCO3 
- add H20 to 1l, sterile filter 
 
PI solution for dead cell exclusion by FACS: 1mg/ml PI (Sigma-Aldrich, Buchs), used 1:500 in FACS 
buffer 
 
LacZ staining solutions 
0.5M EGTA  
47.5g EGTA, add H2O to 200ml, adjust pH to 7.5 using NaOH (solubilizes only in 
neutral pH), add H2O to 250ml 
 
LacZ Fix (50ml) 
0.4ml 25% glutaraldehyde (Sigma-Aldrich, Buchs) 
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0.5ml 0.5M EGTA 
5ml 1M MgCl2 
44.1ml PBS (w/o MgCls/CaCl2, BioWhittaker) 
 
lacZ Wash buffer (500ml) 
1ml 1M MgCl2  
5ml 1%T naDOC (final 0.01%) 
5ml 2% Nonidet-P40 (final 0.02%, Roche) 
489ml PBS (w/o MgCls/CaCl2, BioWhittaker) 
 
LacZ stain (100ml) 
95ml lacZ wash buffer 
4ml 25mg/ml X-gal (dissolved in DMSO) 
0.21g K-ferocyanide 
0.16g K-ferricyanide 
 
Fixation solution 
PFA (1% - 4%) in PBS, dissolved at 55°C for 1 hour 
 
Permeabilization 
PBS containing 0.05% Tween20 (Sigma-Aldrich, Buchs) 
PBS containing 0.1% Saponin (Sigma-Aldrich, Buchs)  
 
Blocking of Biotin/Avidin in tissue sections 
Vector labs-Kit 
 
Blocking of endogenous peroxidases 
PBS containing 0.3% NaN3 + 0.1%H2O2 
 
AEC buffer 
37ml 0.2N acetic acid, 88ml 0.2 Na-acetate, 375ml H2O, pH5.0 
 
Tail lysis buffer 
100mM Tris pH8.5, 5mM Na-EDTA, 0.2% SDS, 200mM NaCl, Proteinase K (100µg/ml, 
store at 4°C, add immediately prior to use) 
 
Trypsin 0.25%/EDTA (Gibco, Lubio, Lucerne) 
 
 
Molecular Biology 
Isolation of genomic DNA from mouse tissue 
Small tissue pieces (tip of tail, embryonic limb) was digested in 700µl of tail lysis buffer containing 
Proteinase K at 55°C for 2-12 hours in an Eppendorf Thermomixer shaker. Undigested tissue was 
pelleted in a tabletop mini centrifuge for 5 minutes at maximum speed. The supernatant was poured 
into an equal volume of isopropanol. DNA was precipitated by vortexing or inverting the tubes, 
thereafter pelleted by centrifugation at maximum speed, washed in 70% ethanol, again pelleted by 
centrifugation, the supernatant discarded and the DNA pellet air dried. TE buffer was added (200-
400µl) and the pellet resuspended after incubation at 55° for 30 minutes. DNA was stored at +4°.  
 
RNA isolation 
RNA isolation was performed in an RNAse-free environment, wearing disposable gloves. Snap-frozen 
(using liquid nitrogen) tissue were homogenized in 1ml of TRI-reagent (Molecular Research Center 
Inc.) and homogenized with a Polytron homogenizer (Kinematica PT1200) for 30-60 seconds on ice, 
thereafter stored for 10’ at RT. After adding of 100µl of bromochloropropanol (Molecular Research 
Center Inc.) the samples were vigorously vortexed for 10 seconds and incubated at RT for 10’. After 
centrifugation (Eppendorf Microcentrifuge, 14000rpm, 10 minutes, 4°C) the aqueous phase was 
transferred to a new Eppendorf tube into an equal volume of isopropanol (Sigma, Buchs), mixed and 
incubated in order to precipitate the RNA at RT for 30-60 minutes. After centrifugation (Eppendorf 
Microcentrifuge, 14000rpm, 30 minutes, 4°C) and aspiration of supernatant the pellet was vortexed in 
1ml of freshly made 75% ethanol and centrifuged again for 10 minutes. The supernatant was 
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completely aspirated and the pellet air dried, thereafter dissolved in 10-30µl of ultra pure H2O. RNA 
concentration was measured with a Gene-Quant machine II (Pharmacia, ratio 260/280nm).  
 
cDNA-synthesis from total RNA 
4µg of total RNA was incubated in H2O containing 500µM dNTP, 10mM DTT, 1x 1st strand buffer 
and 10U RNAse-free DNAseI (final volume 18µl) for 30 minutes at 37°C, cooled on ice for 1 minute, 
1µl each of oligo DT and random primers (dN6-G2) were added (final concentration 500nM), 
incubated 5 minutes at 70°C, cooled on ice for 1 minute. After addition of 1µl of Superscript RTIII 
(200U/µl) the mixture was incubated for 5 minutes at 25°, 60 minutes at 50°C and finally 15’ at 70°. 
H2O was added to achieve the concentration of interest (~50ng/µl). Aliquots were stored at -80°.  
 
Primer design 
Oligonucleotides to be used as primers for PCR reactions were designed using Primer Express ™ 
across intron-exon boundaries where possible, which were searched by blasting genomic DNA versus 
mRNA. Selected primers were blasted to assure specificity. Primers were tested by qPCR and the 
product was run on an agarose gel.  
 
 
PCR 
 
genotyping of HoxA3-Cre and Foxn1-Cre mice 
 
Primers (Hoxa3-Cre) 
TM 2 ggctggaccaatgtaaatattgtc   sense 
TM 4 ggtgggcaactctcctggct antisense 
TM 6 catggactacgggggcactg sense 
Expected product length 
Hoxa3-Cre 280bp  
WT 187bp 
 
Primers (Foxn1-Cre) 
1621 ctc tcc tcc gag tat cca atc tg 
1622 ccc tca cat cct cag gtt cag 
 
PCR reaction mix 
10x Mg free Buffer (Promega) 2.2 ul 
MgCl2 (25 mM from Promega) 1.32 ul 
dNTP mix (2.5 mM each dNTP) 1.32 ul 
Primer mix    3.5 ul 
Taq Polymerase (Promega)  0.18 ul 
ddH20     11.7 ul 
 
*DNA (boiled 5 min/iced 2 min) 1.0 ul     
Total Volume    21 ul 
 
PCR conditions 
 
Start - 1 minute at 61 degrees 
 PCR cycle repeated 29 times: 
  30 seconds at 72 degrees 
  30 seconds at 94 degrees 
  30 seconds at 60 degrees 
 7 minutes at 72 degrees  
 Hold at 4 degrees 
 
genotyping of TGFβRIIlox/lox mice 
Primers  
Forward One 5’- GAA AGA GAT CTA CCA CCA TGT CTA CAA GGA TAG C -3’ 
Reverse One 5’- GGA ATC AAA TCT GAG AAG GGC AAG CAT GGA GC –3’ 
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Reverse Two 5’- GCA AGA ATA TGA GTC CCA GTA GGA ACT CTT TGC C –3’ 
Mix One 
• 100ng template DNA  
• 20.5µl dH2O 
• 2.5µl 10X PCR 
Mix Two 
• 14.75µl dH2O 
• 2.5µl 10X PCR 
• 3µl Mg2+ (50mM) 
• 1µl Forward One (100µM) 
• 2µl Reverse One (100µM) 
• 1µl Reverse Two (100µM) 
• 0.5µl dNTPs (20mM) 
• 0.25µl taq polymerase (0.8 units/µl) 
PCR conditions 
96°C x 5min 
80°C x 5min – add mix two 
 
94°C x 30sec 
65°C x 30sec  30 cycles 
72°C x 30sec 
 
72°C x 5min 
 
primer sequences used for quantitative PCR (sequences 5’→3’) 
 forward  reverse 
IL-7 gtgaggtatgagatgatggacac  gactctgaatcttcatagccttgc 
IL-15 gtctccctaaaacagaggcca  gacagagtgctgtttgcaaggt 
CCL21-c tccaactcacaggcaaagagg  ctctaggtctaccccagggaa 
CCL25 accttcactatgaaactgtggct  cctgtgctggtaacccaggcagca 
CXCL12 AAATCCTCAACACTCCAAAC  GCTTTCTCCAGGTACTCTTG 
c-Kit ligand aaagaatctccgaagaggcca  cacagtcactagtgtcagatgcca 
Ednra tgagatggataagaaccggtg  gcttttggactggtgacaacag 
Ednrb caagacagccaaagattggtgg  agcttcaggatccggctgagg 
Endothelin 1 cgcctggcacatttcagggag  gcaggggccagattctgtcatcct 
Gata-2 aggactaaagtctccgtggga  tgcatgcacttggagagctc 
TGF-beta tgacatgagctacctgggtc  ccacatgactcacactgacg 
 
 
Western blotting 
Lysis of tissue for Western blotting 
Organs were harvested immediately after sacrificing the animal. 50-100mg of tissue was put in 1ml of 
RIPA buffer containing Proteinase-Inhibitor and homogenized using a Polytron homogenizer 
(Kinematica PT1200) for 30-60 seconds on ice. Alternatively, tissue was snap frozen in liquid nitrogen 
and pulverized with dry ice using a pre-cooled mortar and thereafter put in RIPA buffer containing 
Proteinase- and Phosphatase-Inhibitors. Protein concentration was measured using the Bradford assay 
in comparison to a previously established standard curve. Protein lysates were stored at -20° until 
further use.  
 
 
 
SDS-PAGE GEL 
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Glass plates were assemble according to the Mini-Protean 3 Electrophoresis system 
(BIORAD). Gel solutions were prepared immediately prior to use. The separating gel 
was poured and overlayed with H2O and polymerized for 30 minutes. H2O was 
removed and 
the stacking gel poured onto surface of polymerized separating gel, the comb inserted immediately 
therafter, trying to avoid air bubbles. The comb was removed after 30 minutes polymerization, and the 
gel mounted in the electrophoresis apparatus. 1x running buffer was added to the system and the wells 
briefly washed with running buffer using a pipet tip. Samples were prepared by heating them to 95°C 
for 5 minutes in 1x protein sample buffer. Protein was loaded (usually 20-40µg/well), one well was 
loaded with 2µl of marker (Caleidoscope, Biorad), empty wells were loaded with 1x loading buffer. 
The gel was run at 150V for appropriate time, thereafter the glass plates were removed and quickly 
washed in transfer buffer for 5 minutes. Nitrocellulose membranes were cut to the appropriate size and 
pre-wet in transfer buffer. A sandwich was done according to the following figure, preventing air 
bubbles between membrane and gel.  
 
 
 
 
  ANODE +        
 
fiber pad  
      2 Whatman papers 
      membrane   everything soaked  
          in 
      gel    transfer buffer  
      2 Whatman papers 
      fiber pad 
       
  CATHODE - 
 
This gel-membrane sandwich was put in the transfer apparatus, filled with ice-cold 1x transfer buffer. 
Transfer was run at 100V for 1 hour. After transfer, the membrane was rinsed in TPBS and used for 
Western blotting.  
WESTERN BLOT 
Unspecific binding was blocked using Blotto for 1 hour at RT or overnight at 4oC on a shaking 
platform. Primary Antibody incubation was usually performed overnight at 4oC with shaking, diluted in 
Blotto, thereafter the membrane was washed 3-5 times 10 minutes in TPBS at RT.  
2ndary Antibody (HRP-conjugated) incubation was done diluted in Blotto at RT for 45’ on a shaking 
platform, thereafter washed 3-5 times 10min in TPBS at RT. The membrane was incubated for 5min 
with SuperSignal West Pico Chemiluminescent Substrat working solution  (from PIERCE) (mix equal 
volumes of Luminol/Enhancer solution and Stable Peroxide solution) (generated light should last up to 
8hours). The wet membrane was wrapped in plastic foil and an appropriately sized piece of Kodax 
BioMax Light film was usually exposed for 10 seconds to 15 minutes. 
 
 
Preparation of single-cell suspensions 
Organs were dissected immediately after sacrificing the animal and placed in ice-cold PBS-2 or IMDM-
2. The organ was dissociated between two wet, appropriately sized 70µm pore-size meshes using a 
plunger. The resulting dissociated cells were harvested in (A) IMDM-10 (for culture purposes) or (B) in 
PBS-2.  
 
Preparation of thymic stromal cell preparations 
Organs were dissected immediately after sacrificing the animal and placed in ice-cold PBS-2 or 
IMDM-2. The lobes were separated and small cuts were made using small scissors. The thymic lobes 
were placed in digestion solution containing CollagenaseD and DNAse and placed in a waterbath pre-
warmed to 37°C. Every 5 minutes the organs were gently pipetted up and down using a pipet tip with 
an appropriately sized opening (cut if necessary). For TEC quantification, the digest was continued 
until no more clumps were visible. For TEC enrichment, the supernatant was removed after 3-4 rounds 
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of pipetting and fresh Collagenase IV (1mg/ml)/DNAse (10µg/ml) solution was added. Usually two to 
three rounds were performed in this manner, resulting in a single-cell suspension. All further steps 
were performed using PBS-2 containing 5mM EDTA to prevent clumping and adherence of the cells. 
Cells were filtered through a 40µm mesh. 
 
FACS staining  
Staining of filtered cells was performed in PBS-2% on ice in 96-well round bottom plates or in 5ml 
FACS tubes. Antibodies were added at pre-titrated optimal dilutions, incubated on ice for 30 minutes, 
washed in PBS-2%. Appropriate secondary reagent was added where applicable. Flow cytometric 
acquisition was performed on a FACS Calibur (BD, Allschwil). Data was analysed using Cell Quest 
Pro Software (BD, Allschwil) or FlowJo 8.2 (Tree Star Inc., Stanford) 
 
in vitro T cell proliferation 
96-well tissue culture plates were pre-incubated at 37°C for 1 hour with a-CD3 and a-CD28 (4µg/ml) 
in 50µl PBS/well. Thereafter wells were washed and cells added at 5x104 /well in a final volume of 
200µl IMDM-10%. After 48 hours 50µl of supernatant was removed and 1µCi/well of 3H-Thymidine 
was added. 24 hours later the cells were harvested and counted in a b-scintillation counter.  
 
TGFβ-ELISA 
ELISA was performed in a 96-well flat bottom high absorbance plate (ebioscience Inc., San Diego, 
CA, USA) according to the manufacturer. The ELISA plate was coated with 100 µl/well of capture 
antibody in Coating Buffer and the plate was sealed the plate and incubated overnight at 4°C. 
Thereafter washed 5 times with >250 µl/well Wash Buffer (diluted to 1X). Allowing time for soaking 
(~ 1 minute) during each wash step increases the effectiveness of the washes. Blot plate on absorbent 
paper to remove any residual buffer. 
Dilute 1 part 5x concentrated Assay Diluent with 4 parts DI water. Block wells with 200 µl/well of 1x 
Assay Diluent. Incubate at room temperature for 1 hour. Aspirate/wash 5x  
Acid Activation of Samples: To activate latent TGF-ß1 to the immunoreactive form, the samples (but 
not standards) must be acidified, and then neutralized. Animal serum used in culture media may 
contain high levels of latent TGF-ß1, so controls should be run to determine baseline concentrations of 
TGF-ß1 in culture media. 
Tissue culture supernatants: Per 100 ul of sample, add 20 ul of 1N HCl; incubate 10 minutes at room 
temperature, then neutralize with 20 ul of 1N NaOH. [When calculating final sample concentration, 
correct to the dilution factor of 1.4.] 
Serum or plasma: Dilute 1:5 in PBS, then treat as above for supernatants. 
Using Assay Diluent, dilute standards as noted on the Certificate of Analysis (C of A). Add 100 µl/well 
of standard to the appropriate wells. Perform 2-fold serial dilutions of the top standards to make the 
standard curve. Add 100 µl/well of your acid-activated samples to the appropriate wells. Cover or seal 
the plate and incubate at room temperature for 2 hours (or overnight at 4°C for maximal sensitivity). 
Wash 5 times as above. 
Add 100 µl/well of detection antibody diluted in 1X Assay Diluent (dilute as noted on C of A). Seal the 
plate and incubate at room temperature for 1 hour. 
Aspirate/wash. Repeat for a total of 5 washes. 
Add 100 µl/well of Avidin-HRP diluted in 1X Assay Diluent. Seal the plate and incubate at room 
temperature for 30 minutes. 
Aspirate and wash. In this wash step, soak wells in Wash Buffer for 1 to 2 minutes prior to aspiration. 
Repeat for a total of 7 washes. 
Add 100 µl/well of Substrate Solution to each well. Incubate plate at room temperature for 15 minutes. 
Add 50 µl of Stop Solution (2N H2SO4) to each well. 
Read plate at 450 nm. If wavelength subtraction is available, subtract the values of 570 nm from those 
of 450 nm and analyze data. 
 
Histology 
Freshly dissected organs were embeddedin OCT compound (Medite, Switzerland) in Tissue-Tek 
Cryomolds (Miles Inc., Elkhart, USA). Tissues were frozen in methyl-butane pre-cooled with dry ice 
and then  stored at -80°C until further use.  
Alternatively the organ was fixed in 4% PFA/PBS overnight, washed in PBS an thereafter parafinized.  
 
HE staining 
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OCT embedded tissues were cut at 5-10µm thickness usin a cryostat. Tissues were air dried for 30 
minutes to overnight at RT, thein either frozen at -80°C (wrapped in aluminium foil) or processed 
directly, Sections were fixed in Delaunay’s fixation solution for 1’ rehydrated in a series of ethanol 
dilutions for 1 minute each (100% - 96% - 70% -50% - 0%), stained in Meyer’s Hämalaun for 2 
minutes, washed 3 minutes in warm water, stained in Erythrosin, washed again 2 minutes in water and 
dehydrated in increasing ethanol concentrations. After air drying the slides were covered with Pertex 
and cover slips.  
 
Immunohistochemistry 
5-10µm sections were fixed in 4% PFA/PBS at RT for 15 minutes or alternatively in pre-cooled 
Acetone (Sigma, Buchs) for 10’ at -20°, thereafter incubated in PBS-Tween0.05% for 5 minutes. 
Unspecific binding was reduced by blocking with PBS-2% BSA-Tween0.05%, biotin/avidin block was 
used to block endogenous biotin. Incubation with primary antibody was performed in PBS-
Tween0.05% for 2 hours up to overnight. Sections were washed thereafter 3 times in PBS-
Tween0.05% 5 minutes each, and incubated with secondary antibody for 30’ at RT of riwth SA-
conjugated horseradish peroxidase. Sections were developed using AEC and counterstained with 
hemalaun. Alternatively, fluorochrome-labeled primary or secondary antibodies were used to detect the 
antigens of interest using a confocal microscope (Carl-Zeiss AG, Feldbach, Switzerland).  
 
β-galactosidase staining 
 
Tissue processing: 
Embryos up to E14: whole mount possible, yet cutting into smaller pieces (e.g. removing head and 
limbs helps penetration of fixative and staining solution 
 
Fixation in LacZ fixation solution: 
Whole mount: depending on the size of the tissue 2-12 hours at 4°C gave adequate results.   
wash with PBS at least 3x 5 minutes 
 
X-gal staining 
Whole mount: incubate in LacZ staining solution at 30-37° overnight  
wash with PBS at least 3x 5 minutes 
Fix again in 0.2% glutaraldehyde/PBS overnight at 4°C 
wash with PBS at least 3x 5 minutes 
proceed to paraffin embedding 
 
staining for intracellular TGFβ1-3 
Cells were stained for surface antigens for 30 minutes on ice in FACS buffer, washed, fixed in 2% PFA 
for 10 minutes at room temperature, washed in PBS-0.2% Saponin, and stained with Fluos-labelled a-
TGFβ (clone 1D11) 
 
BrdU staining for measurement of proliferation 
Cells were stained for surface antigens for 30 minutes on ice in FACS buffer, washed, fixed in 
Cytofix/Cytoperm buffer (BD biosciences, Allschwil) for 30 minutes on ice, washed in Wash/Perm 
buffer (BD biosciences, Allschwil), resuspended in 10%DMSO/90% FCS and frozen at -80°C for at 
least 12 hours, thereafter thawed in 37°C waterbath, washed in FACS buffer, re-fixed in 
Cytofix/Cytoperm buffer for 10-15 minutes on ice, washed, incubated in 1x DNAse buffer containing 
RNAse-free DNAse (Roche Diagnostics, Basel) at 4U/ml in 37° C waterbath for 60 minutes, washed in 
Wash/Perm buffer, incubated with a-BrdU-FITC (BD Biosciences or ebioscience (clone PRB-1), 
washed in Wash/Perm buffer and finally analyse at a flow rate of 400 events/second. This method has 
the advantage of excellent preservation of FSC/SSC characteristics.  
 
Fetal thymic organ culture and lymphocyte depletion 
Fetal thymic lobes were placed on Nucleopore track-edge membrane filters (shiny side up), which was 
placed on the surface of medium in a 12- or 24-well plate. Lymphocyte depletion was performed prior 
to transplantation of the thymic grafts into nude recipients for a 5-day culture period using 2-deoxy-
Guanosine (2dGuo) (Sigma-Aldrich, Buchs, Switzerland). Deoxy-Guanosine, final concentration 
1.35mM in IMDM-10%FCS 
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In vivo BrdU labeling  
To measure TEC proliferation, mice (12 – 18 weeks of age) were first injected with 1mg BrdU (Sigma-
Aldrich, Buchs, Switzerland) and, thereafter, fed with BrdU-containing drinking water (0.8mg/ml). On 
day 14, thymic stromal cells were isolated as detailed above, stained for the expression of CD45 and 
MHCII, and analyzed for BrdU incorporation. 
 
 
 
Intrathymic FITC injection for the detection of recent thymic emigrants  
Anesthesized animals were injected in both thymic lobes wit 10µl of 125µg/ml FITC (Sigma, Buchs, 
Switzerland) diluted in PBS. 16-24 hours later the mice were analysed for FITC+ CD4+ or CD8+ cells 
in thymus and periphery.  
 
 
Hematopoetic stem cell transplantation  
Donors:  
Bone marrow was flushed from femur and tibia using IMDM-10%. Cells were washed and filtered 
through a 40µm mesh. For T cell depletion anti-CD4 (clone RL172), anti-CD8 (clone 31M) and anti-
Thy1.2 (clone H01349) supernatants were added to the cells. After washing T cell elimination was 
achieved using Low-Tox®-M rabbit complement lysis (Cedarlane, Bioreba AG, Switzerland).   
 
Recipients:  
Eight week old TGFbRIIlox/lox and TGFbRIIlox/lox::Foxn1-Cre mice were lethally irradiated (9.5 Gy) 
using a 137Cs source (0.81 Gy/min) and were subsequently intravenously infused with 107 T cell-
depleted bone marrow cells derived from B6.CD45.1 mice in a total volume of 250µl HBSS.  
Transplanted mice were housed in single ventilated cages.  
 
 
KGF treatment 
Mice were injected intraperitoneally on 3 subsequent days with either HBSS or recombinant human 
KGF (kindly provided by Amgen, Thousand Oaks, CA, USA) at a dose of 5mg/kg per day. Analysis 
was performed 14 days after the last injection. 
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